Register Login

Vir Biotechnology (VIR)

(10% Negative) Vir Biotechnology (VIR) Announces Delay in trial Trials for chronic hepatitis delta (CHD) Due to Geopolitical Situation, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Jan. 29, 2026, 8:38 p.m.

    📋 Vir Biotechnology (VIR) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 08:07:34

    Event Type: Clinical Trial Update

    Event Details:

    Vir Biotechnology (VIR) Announces Clinical Trial Update Vir Biotechnology (VIR) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: trial, alone
    • Diseases/Conditions: chronic hepatitis delta (CHD)
    • Clinical Stage: Phase 1, Phase 2 trial
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Geopolitical Situation, Patient Enrollment, Regulatory Process
    • Collaboration: American Society of Clinical Oncology Genitourinary Cancers Symposium
    • Updated Timeline: Q4 2027
      • targeting the hepatitis B surface antigen (HBsAg). It is designed to inhibit the entry of hepatitis B and hepatitis delta viruses into hepatocytes and to reduce the level of circulating viral and subviral particles in the blood. Tobevibart was identified using Vir Biotechnology’s proprietary mAb discovery platform. The Fc domain has been engineered to increase immune engagement and clearance of HBsAg immune complexes and incorporates Xencor’s Xtend™ technology to extend half-life. Tobevibart is administered subcutaneously, and it is currently in clinical development for the treatment of patients with chronic hepatitis delta.Elebsiran is an investigational hepatitis B virus-targeting small interfering ribonucleic acid (siRNA) licensed from Alnylam Pharmaceuticals, Inc. It is designed to degrade hepatitis B virus RNA transcripts and limit the production of HBsAg. Current data indicate that it has the potential to have direct antiviral activity against hepatitis B virus and hepatitis delta virus. Elebsiran is administered subcutaneously, and it is currently in clinical development for the treatment of patients with chronic hepatitis delta. About Chronic Hepatitis Delta (CHD)CHD is the most severe form of chronic viral hepatitis4 and was recently classified as carcinogenic by the International Agency for Research on Cancer.5 People living with the disease rapidly progress to cirrhosis, liver failure6 and liver-related death.4 There are currently no approved treatments in the U.S., and options are limited in the European Union and globally.About VIR-5500
      • expected in the first quarter of 2027
      • expected in the second half of 2026

    🔬 Clinical Development Pipeline (Vir Biotechnology):

    Product Type Development Stage Therapeutic Area Source
    Artemether-lumefantrine drug combination DRUG Phase PHASE4 Falciparum Malaria ClinicalTrials.gov
    VIR-5525 DRUG Phase PHASE1 Solid Tumor Malignancies ClinicalTrials.gov
    Elebsiran DRUG Phase PHASE3 Viral Hepatitis ClinicalTrials.gov
    Tobevibart DRUG Phase PHASE3 Viral Hepatitis ClinicalTrials.gov
    IMV101 treatment DRUG Phase PHASE1 Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ClinicalTrials.gov
    Bulevirtide DRUG Phase PHASE3 Viral Hepatitis ClinicalTrials.gov
    VIR-5818 DRUG Phase PHASE1 Locally Advanced or Metastatic HER2-Expressing Cancers ClinicalTrials.gov
    specialized food product based on ice cream 3 OTHER Approved Non-Alcoholic Steatohepatitis (NASH) ClinicalTrials.gov
    Control DRUG Phase PHASE3 Gastric Adenocarcinoma ClinicalTrials.gov
    platinum-based doublet chemotherapy. DRUG Phase PHASE3 Non-Small Cell Lung Cancer ClinicalTrials.gov
    VIR-5500 DRUG Phase PHASE1 Hormone-refractory Prostate Cancer ClinicalTrials.gov
    MR001 Bispecific Antibody for Injection DRUG Phase PHASE1 Triple-Negative Breast Cancer (TNBC) ClinicalTrials.gov
    Fludarabine DRUG Phase PHASE1 Gastric Cancer ClinicalTrials.gov
    Cyclophosphamide DRUG Phase PHASE1 Gastric Cancer ClinicalTrials.gov
    CB CAR-NK182 BIOLOGICAL Phase PHASE1 Gastric Cancer ClinicalTrials.gov
    Placebo DRUG Phase PHASE2 Primary Sjögren Syndrome ClinicalTrials.gov
    ESG206 DRUG Phase PHASE2 Primary Sjögren Syndrome ClinicalTrials.gov
    GT307 injection BIOLOGICAL Approved Solid Tumor, Adult ClinicalTrials.gov
    CAR-T BIOLOGICAL Phase PHASE1 AML (Acute Myeloid Leukemia) ClinicalTrials.gov
    GST-HG141 Placebo DRUG Phase PHASE3 Chronic Hepatitis b ClinicalTrials.gov
    GST-HG141 DRUG Phase PHASE3 Chronic Hepatitis b ClinicalTrials.gov
    UB-VV410 DRUG Phase PHASE1 Systemic Lupus Erythematosus ClinicalTrials.gov
    Methylprednisolone DRUG Phase PHASE1 Acute Respiratory Failure ClinicalTrials.gov
    GT201 in combination with PD-1 inhibitors BIOLOGICAL Approved HNSCC ClinicalTrials.gov
    Vebreltinib combined with platinum-based doublet chemotherapy. DRUG Phase PHASE3 Non-Small Cell Lung Cancer ClinicalTrials.gov
    Cisplatin combined with Etoposide DRUG Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Temozolomide DRUG Phase PHASE2 Glioblastoma ClinicalTrials.gov
    PLB1001 DRUG Phase PHASE2 Glioblastoma ClinicalTrials.gov
    adjuvant placebo BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    approved influenza vaccine BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    influenza vaccine（BK01 adjuvnat） BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    STSA-1301 subcutaneous injection DRUG Phase PHASE1 Primary Immune Thrombocytopenia (ITP) ClinicalTrials.gov
    CAR-T cell therapy BIOLOGICAL Phase EARLY_PHASE1 R/R Aggressive B-cell Lymphoma ClinicalTrials.gov
    AKM Lab-01 DRUG Approved Overweight , Obesity ClinicalTrials.gov
    Probiotic DRUG Approved Anxiety Depression ClinicalTrials.gov
    TCR-T cells BIOLOGICAL Phase EARLY_PHASE1 KRAS G12V ClinicalTrials.gov
    PLB1004 DRUG Phase PHASE2 Non-Small-Cell Lung Cancer ClinicalTrials.gov
    Lyophilized Human Rabies Vaccine (Human Diploid Cell) DRUG Phase PHASE1 RabiesPrevention ClinicalTrials.gov
    Personalized neoantigen tumor vaccine BIOLOGICAL Phase PHASE1 B-cell Non-Hodgkin's Lymphoma (B-NHL) ClinicalTrials.gov
    IASO208 injection GENETIC Phase PHASE1 Relapsed/Refractory B-cell Malignancies ClinicalTrials.gov
    UX-DA001 BIOLOGICAL Phase PHASE1 Parkinson Disease, Idiopathic ClinicalTrials.gov
    XW-LTH-03 Infusion BIOLOGICAL Phase PHASE1 Stage IV Gastric Cancer ClinicalTrials.gov
    GT801 Injection BIOLOGICAL Phase EARLY_PHASE1 Moderate to Severe Refractory Autoimmune Disease ClinicalTrials.gov
    Placebo Group BIOLOGICAL Phase PHASE1 Genital Herpes ClinicalTrials.gov
    High-Dose Cohort BIOLOGICAL Phase PHASE1 Genital Herpes ClinicalTrials.gov
    Mid-Dose Cohort BIOLOGICAL Phase PHASE1 Genital Herpes ClinicalTrials.gov
    Low-Dose Cohort BIOLOGICAL Phase PHASE1 Genital Herpes ClinicalTrials.gov
    FL115+PD-1 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    FL115 DRUG Phase PHASE1 Locally Advanced/Metastatic Solid Tumors ClinicalTrials.gov
    KH658 DRUG Phase PHASE1 Age-Related Macular Degeneration ClinicalTrials.gov
    ASD141 BIOLOGICAL Phase PHASE1 Metastatic Solid Tumor ClinicalTrials.gov
    MSC BIOLOGICAL Phase PHASE1 Ischemic Stroke ClinicalTrials.gov
    SR750 tablet DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Gemcitabine (GEM) DRUG Phase PHASE1 Pancreatic Ductal Adenocarcinoma (PDAC) ClinicalTrials.gov
    Nab-paclitaxel DRUG Phase PHASE1 Pancreatic Ductal Adenocarcinoma (PDAC) ClinicalTrials.gov
    Irinotecan Liposome Injection combined with 5-FU/LV DRUG Phase PHASE1 Pancreatic Ductal Adenocarcinoma (PDAC) ClinicalTrials.gov
    MR001 DRUG Phase PHASE1 Pancreatic Ductal Adenocarcinoma (PDAC) ClinicalTrials.gov
    KH631 DRUG Phase PHASE1 Age-Related Macular Degeneration ClinicalTrials.gov
    Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules) BIOLOGICAL Phase PHASE4 Diarrhea ClinicalTrials.gov
    GT719 Injection BIOLOGICAL Phase EARLY_PHASE1 Hematological Malignancy (Leukemia- Lymphoma) ClinicalTrials.gov
    2D UC-MSC group DRUG Phase PHASE1 Severe Aplastic Anemia (SAA) ClinicalTrials.gov
    3D hypoxia-preconditioned UC-MSC group DRUG Phase PHASE1 Severe Aplastic Anemia (SAA) ClinicalTrials.gov
    Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules) or Placebo BIOLOGICAL Phase PHASE4 Diarrhea ClinicalTrials.gov
    wIPV BIOLOGICAL Phase PHASE3 Poliomyelitis ClinicalTrials.gov
    sIPV BIOLOGICAL Phase PHASE3 Poliomyelitis ClinicalTrials.gov
    SAL003 140 mg DRUG Phase PHASE3 Hyperlipidemias ClinicalTrials.gov
    specialized food product based on ice cream 2 OTHER Approved Non-Alcoholic Steatohepatitis (NASH) ClinicalTrials.gov
    specialized food product based on ice cream OTHER Approved Non-Alcoholic Steatohepatitis (NASH) ClinicalTrials.gov
    NaCl solution Placebo BIOLOGICAL Phase PHASE3 Herpes Zoster ClinicalTrials.gov
    Recombinant Zoster Vaccine (CHO Cell) BIOLOGICAL Phase PHASE3 Herpes Zoster ClinicalTrials.gov
    YTS109 cell DRUG Phase PHASE1 Autoimmune Hemolytic Anemia ClinicalTrials.gov
    9-HPV vaccine BIOLOGICAL Phase PHASE2 HPV Infection ClinicalTrials.gov
    High dose for 15-HPV vaccine BIOLOGICAL Phase PHASE2 HPV Infection ClinicalTrials.gov
    Medium dose for 15-HPV vaccine BIOLOGICAL Phase PHASE2 HPV Infection ClinicalTrials.gov
    Pemetrexed+（carboplatin or Cisplatin）with or without Sintilimab DRUG Phase PHASE3 Non-Small-Cell Lung Cancer ClinicalTrials.gov
    ANS014004 + Osimertinib DRUG Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    ANS014004 + PLB1004 DRUG Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    Placebo 420mg+Atorvastatin DRUG Phase PHASE2 Hypercholesterolemia and Mixed Dyslipidemia ClinicalTrials.gov
    Placebo 140mg+Atorvastatin DRUG Phase PHASE2 Hypercholesterolemia and Mixed Dyslipidemia ClinicalTrials.gov
    SAL003 420mg+Atorvastatin DRUG Phase PHASE2 Hypercholesterolemia and Mixed Dyslipidemia ClinicalTrials.gov
    SAL003 140mg+Atorvastatin DRUG Phase PHASE2 Hypercholesterolemia and Mixed Dyslipidemia ClinicalTrials.gov
    NW-101C BIOLOGICAL Phase PHASE1 Solid Metastatic Tumor ClinicalTrials.gov
    CD19 CAR T cells DRUG Phase EARLY_PHASE1 B-Cell Acute Lymphoblastic Leukemia, Adult ClinicalTrials.gov
    Conventional Toothbrush DEVICE Approved Oral Hygiene ClinicalTrials.gov
    Charcoal-Impregnated Toothbrush DEVICE Approved Oral Hygiene ClinicalTrials.gov
    SA1211 injection placebo DRUG Phase PHASE1 Chronic Hepatitis B ClinicalTrials.gov
    SA1211 injection DRUG Phase PHASE1 Chronic Hepatitis B ClinicalTrials.gov
    allogeneic umbilical cord blood-derived CAR-T targeting CD19 and BCMA DRUG Phase EARLY_PHASE1 SLE - Systemic Lupus Erythematosus ClinicalTrials.gov
    Placebo (Saline solution) BIOLOGICAL Phase PHASE3 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell) BIOLOGICAL Phase PHASE3 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    claudin18.2 CAR-T DRUG Phase EARLY_PHASE1 Claudin18.2 Positive Advanced Solid Tumors ClinicalTrials.gov
    CD19/BCMA CAR T-cells DRUG Phase EARLY_PHASE1 SLE - Systemic Lupus Erythematosus ClinicalTrials.gov
    human umbilical cord mesenchymal stem cell BIOLOGICAL Phase PHASE1 Lumbar Discogenic Pain ClinicalTrials.gov
    hucMSCs BIOLOGICAL Phase PHASE2 Premature Ovarian Failure ClinicalTrials.gov
    intrauterine injection PROCEDURE Phase PHASE1 Infertility, Female ClinicalTrials.gov
    human umbilical cord mesenchymal stem cell complex collagen BIOLOGICAL Phase PHASE1 Infertility, Female ClinicalTrials.gov
    total endoscopic extraction of lumbar nucleus pulposus PROCEDURE Phase PHASE1 Lumbar Disc Degeneration ClinicalTrials.gov
    human umbilical cord mesenchymal stem cell suspension BIOLOGICAL Phase PHASE1 Lumbar Disc Degeneration ClinicalTrials.gov
    Increased Physical activity BEHAVIORAL Approved Sedentary Behavior ClinicalTrials.gov
    Decreased Physical Activity BEHAVIORAL Approved Sedentary Behavior ClinicalTrials.gov
    Intraarticular injection PROCEDURE Phase PHASE2 Osteoarthritis, Knee ClinicalTrials.gov
    High dose mesenchymal stem cells BIOLOGICAL Phase PHASE2 Osteoarthritis, Knee ClinicalTrials.gov
    Low dose mesenchymal stem cells BIOLOGICAL Phase PHASE2 Osteoarthritis, Knee ClinicalTrials.gov
    umbilical cord mesenchymal stem cell BIOLOGICAL Phase PHASE2 Spinocerebellar Ataxia Type 1 ClinicalTrials.gov
    Intrathecal injection PROCEDURE Phase PHASE2 Spinocerebellar Ataxia Type 1 ClinicalTrials.gov
    Intravenous infusion PROCEDURE Phase PHASE2 Spinocerebellar Ataxia Type 1 ClinicalTrials.gov
    CD19 CAR-T cells DRUG Phase PHASE2 ALL ClinicalTrials.gov
    AFP Specific T Cell Receptor T Cells BIOLOGICAL Phase PHASE1 Hepatic Cell Carcinoma ClinicalTrials.gov
    BAFF-R CAR-T DRUG Phase PHASE1 DLBCL ClinicalTrials.gov
    NK cell preparation DRUG Phase PHASE1 Advanced Solid Tumors (Phase 1) ClinicalTrials.gov
    allogeneic umbilical cord blood-derived CAR-T DRUG Phase EARLY_PHASE1 B-Cell Acute Lymphoblastic Leukemia, Adult ClinicalTrials.gov
    GT729 Injection BIOLOGICAL Phase EARLY_PHASE1 cGVHD ClinicalTrials.gov
    PEG-IFNα DRUG Phase PHASE1 Hepatitis B, Chronic ClinicalTrials.gov
    TDF DRUG Phase PHASE1 Hepatitis B, Chronic ClinicalTrials.gov
    VIR-2218 DRUG Phase PHASE1 Hepatitis B, Chronic ClinicalTrials.gov
    VIR-3434 DRUG Phase PHASE1 Hepatitis B, Chronic ClinicalTrials.gov
    CAR19-BCMA dual-target CAR-T DRUG Phase EARLY_PHASE1 Multiple Myeloma ClinicalTrials.gov
    NW-301D DRUG Phase PHASE1 Tumor, Solid ClinicalTrials.gov
    NW-301V DRUG Phase PHASE1 Tumor, Solid ClinicalTrials.gov
    UBT251 DRUG Phase PHASE2 Obesity &Amp; Overweight ClinicalTrials.gov
    STSP-0601 for Injection DRUG Phase PHASE3 Hemophilia ClinicalTrials.gov
    UX-GIP001 BIOLOGICAL Phase EARLY_PHASE1 Epilepsy ClinicalTrials.gov
    Peripheral iv BIOLOGICAL Phase PHASE1 Hepatitis B ClinicalTrials.gov
    Adze1.C DRUG Phase PHASE1 Metastatic Melanoma ClinicalTrials.gov
    MWN109 tablet DRUG Phase PHASE1 Overweight or Obesity ClinicalTrials.gov
    PD-1 inhibitor DRUG Phase EARLY_PHASE1 Pancreatic Cancer Resectable ClinicalTrials.gov
    Fixed neoantigen tumor vaccine BIOLOGICAL Phase EARLY_PHASE1 Pancreatic Cancer Resectable ClinicalTrials.gov
    Genome Sequencing GENETIC Approved Genetic Predisposition to Disease ClinicalTrials.gov
    Placebo Gum OTHER Approved Sleep Deprivation ClinicalTrials.gov
    CAR T cells DRUG Phase PHASE3 Gastric Adenocarcinoma ClinicalTrials.gov
    RPESC-RPE-4W BIOLOGICAL Phase PHASE1 Dry Age-related Macular Degeneration ClinicalTrials.gov
    NRTI DRUG Phase PHASE2 Hepatitis D, Chronic ClinicalTrials.gov
    Shingrix BIOLOGICAL Phase PHASE2 Herpes Zoster ClinicalTrials.gov
    HZ Vaccine (IN001) BIOLOGICAL Phase PHASE2 Herpes Zoster ClinicalTrials.gov
    hUC-MSCs treatment (low dose) DRUG Phase PHASE2 Acute Ischemic Stroke AIS ClinicalTrials.gov
    hUC-MSCs treatment (high dose) DRUG Phase PHASE2 Acute Ischemic Stroke AIS ClinicalTrials.gov
    IxCell hUC-MSC-S (Human Umbilical Cord Mesenchymal Stem Cells) DRUG Phase PHASE2 Ischemic Stroke ClinicalTrials.gov
    TIL injection BIOLOGICAL Phase PHASE1 Solid Tumors, Adult ClinicalTrials.gov
    AC699 DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    pembrolizumab DRUG Phase PHASE1 Locally Advanced or Metastatic HER2-Expressing Cancers ClinicalTrials.gov
    HuL001 DRUG Phase PHASE1 Idiopathic Pulmonary Fibrosis ClinicalTrials.gov
    mRNA GENETIC Phase EARLY_PHASE1 Duchenne Muscular Dystrophy (DMD) ClinicalTrials.gov
    Pandora-2 app with low levels of personalization, interaction, monitoring and feedback OTHER Approved Depression ClinicalTrials.gov
    Pandora-1 app with high levels of personalization, interaction, monitoring and feedback BEHAVIORAL Approved Depression ClinicalTrials.gov
    DXC014 DRUG Phase PHASE1 Small Cell Lung Cancer ClinicalTrials.gov
    Psychoeducational intervention OTHER Approved Depression ClinicalTrials.gov
    Predictplusprevent intervention BEHAVIORAL Approved Depression ClinicalTrials.gov
    Etribnabdione 50 mg BID DRUG Phase PHASE2 Peripheral Arterial Disease ClinicalTrials.gov
    Etribnabdione 25 mg BID DRUG Phase PHASE2 Peripheral Arterial Disease ClinicalTrials.gov
    Conventional treatment (conventional treatment with adequate offloading and metabolic control, +/- antibiotic). PROCEDURE Phase PHASE4 Foot Ulcers, Diabetic ClinicalTrials.gov
    Topical application of Plasma Rich in Growth Factors (PRGF) DRUG Phase PHASE4 Foot Ulcers, Diabetic ClinicalTrials.gov
    50561 low dose DRUG Phase PHASE2 Alzheimer's Disease ClinicalTrials.gov
    50561 high dose DRUG Phase PHASE2 Alzheimer's Disease ClinicalTrials.gov
    DXC008 DRUG Phase PHASE1 Prostate Cancer ClinicalTrials.gov
    ESG406 DRUG Phase PHASE1 Locally Advanced/Metastatic Solid Tumors ClinicalTrials.gov
    Rapamycin DRUG Phase PHASE1 Large B-cell Lymphoma ClinicalTrials.gov
    UB-VV400 GENETIC Phase PHASE1 Large B-cell Lymphoma ClinicalTrials.gov
    Metformin Hydrochloride DRUG Phase PHASE4 Polycystic Ovary Syndrome ClinicalTrials.gov
    UBT251 Injection 6.0 mg and UBT251 Injection Placebo DRUG Phase PHASE2 Obesity &Amp; Overweight ClinicalTrials.gov
    UBT251 Injection 4.0 mg (ID 1.0 mg) and UBT251 Injection Placebo DRUG Phase PHASE2 Obesity &Amp; Overweight ClinicalTrials.gov
    UBT251 Injection 4.0 mg (ID 0.5 mg) and UBT251 Injection Placebo DRUG Phase PHASE2 Obesity &Amp; Overweight ClinicalTrials.gov
    UBT251 Injection 2.0 mg and UBT251 Injection Placebo DRUG Phase PHASE2 Obesity &Amp; Overweight ClinicalTrials.gov
    ESG401 DRUG Phase PHASE1 Neoplasms, Breast ClinicalTrials.gov
    Fluimucil 600mg granules DRUG Phase PHASE4 COPD (Chronic Obstructive Pulmonary Disease) ClinicalTrials.gov
    Taneasy 600mg granules DRUG Phase PHASE4 COPD (Chronic Obstructive Pulmonary Disease) ClinicalTrials.gov
    Optional 12-week follow up questionnaire OTHER Preclinical Diabetic Foot ClinicalTrials.gov
    Main questionnaire OTHER Preclinical Diabetic Foot ClinicalTrials.gov
    Nidadd DRUG Phase PHASE3 Hyperlipidemia ClinicalTrials.gov
    LXR015-1 DRUG Phase PHASE1 HIV Infections ClinicalTrials.gov
    PBT2 DRUG Phase PHASE2 Alzheimer's Disease ClinicalTrials.gov
    CYT004-MelQbG10 BIOLOGICAL Phase PHASE1 Malignant Melanoma ClinicalTrials.gov
    DCB-AD1 DRUG Phase PHASE2 Dementia, Alzheimer Type ClinicalTrials.gov
    Abilify (aripiprazole) DRUG Phase PHASE4 Hyperprolactinemia ClinicalTrials.gov
    CYT005-AllQbG10 BIOLOGICAL Phase PHASE1 Hypersensitivity ClinicalTrials.gov
    Combigan Ophthalmic Solutiom DRUG Phase PHASE4 Glaucoma ClinicalTrials.gov
    HBV DNA Vaccine BIOLOGICAL Phase PHASE2 Chronic Hepatitis B Patients With HBeAg-positive ClinicalTrials.gov
    CYT006-AngQb BIOLOGICAL Phase PHASE2 Mild Essential Hypertension ClinicalTrials.gov
    House dust mite allergen extract in combination with CYT003-QbG10-placebo DRUG Phase PHASE2 Perennial Allergic Rhinoconjunctivitis ClinicalTrials.gov
    CYT005-AllQbG10 (combination of house dust mite allergen extract with CYT003-QbG10) DRUG Phase PHASE2 Perennial Allergic Rhinoconjunctivitis ClinicalTrials.gov
    GHB11L1 BIOLOGICAL Phase PHASE2 Influenza, Human ClinicalTrials.gov
    Nattokinase DRUG Approved Hyperlipidemia ClinicalTrials.gov
    GHB01L1 BIOLOGICAL Phase PHASE1 Seasonal Human Influenza ClinicalTrials.gov
    Hyaluronic Acid Intraarticular injection DEVICE Phase PHASE4 Joint Disease ClinicalTrials.gov
    PRGF Intraarticular injection DEVICE Phase PHASE4 Joint Disease ClinicalTrials.gov
    CYT004-MelQbG10 intra nodal injection BIOLOGICAL Phase PHASE2 Malignant Melanoma ClinicalTrials.gov
    CYT004-MelQbG10 + Imiquimod BIOLOGICAL Phase PHASE2 Malignant Melanoma ClinicalTrials.gov
    CYT004-MelQbG10 + Montanide + Imiquimod BIOLOGICAL Phase PHASE2 Malignant Melanoma ClinicalTrials.gov
    CYT004-MelQbG10 + Montanide BIOLOGICAL Phase PHASE2 Malignant Melanoma ClinicalTrials.gov
    BMEC-1217B DRUG Phase PHASE1 Asthma ClinicalTrials.gov
    mesenchymal stem cells BIOLOGICAL Phase PHASE1 Type 2 Diabetes Mellitus ClinicalTrials.gov
    CYT002-NicQb BIOLOGICAL Phase PHASE2 Smokers ClinicalTrials.gov
    CYT003-QbG10 DRUG Phase PHASE2 Perennial Allergy to House Dust Mite and/or Cat ClinicalTrials.gov
    TG-873870(Nemonoxacin) DRUG Phase PHASE2 Community-Acquired Pneumonia ClinicalTrials.gov
    GHB04L1 BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    autologous bone marrow mononuclear cells and umbilical cord mesenchymal stem cells BIOLOGICAL Phase PHASE1 Type 1 Diabetes Mellitus ClinicalTrials.gov
    donor natural killer cell infusion BIOLOGICAL Phase PHASE1 Brain and Central Nervous System Tumors ClinicalTrials.gov
    CYT013-IL1bQb DRUG Phase PHASE1 Type 2 Diabetes Mellitus ClinicalTrials.gov
    conventional therapy plus high dose hUC-MSCs treatment BIOLOGICAL Phase PHASE1 Liver Cirrhosis ClinicalTrials.gov
    conventional therapy plus medium dose hUC-MSCs treatment BIOLOGICAL Phase PHASE1 Liver Cirrhosis ClinicalTrials.gov
    conventional therapy plus low dose hUC-MSCs treatment BIOLOGICAL Phase PHASE1 Liver Cirrhosis ClinicalTrials.gov
    Nemonoxacin DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    human cord blood mononuclear cells and human umbilical cord mesenchymal stem cells BIOLOGICAL Phase PHASE1 Autism ClinicalTrials.gov
    human cord blood mononuclear cells BIOLOGICAL Phase PHASE1 Autism ClinicalTrials.gov
    foldable capsular vitreous body(FCVB) DEVICE Phase EARLY_PHASE1 Retinal Detachment ClinicalTrials.gov
    Levofloxacin DRUG Phase PHASE3 Pneumonia ClinicalTrials.gov
    Regular human insulin DRUG Phase PHASE3 Diabetes Mellitus ClinicalTrials.gov
    Generex Oral-lyn™ DRUG Phase PHASE3 Diabetes Mellitus ClinicalTrials.gov
    Nemonoxacin Malate Sodium Chloride DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Hormone Replacement Therapy DRUG Phase PHASE1 Premature Ovarian Failure， ClinicalTrials.gov
    hUCMSCs and hCBMNCs BIOLOGICAL Phase PHASE1 Premature Ovarian Failure， ClinicalTrials.gov
    human umbilical cord mesenchymal stem cells BIOLOGICAL Phase PHASE1 Premature Ovarian Failure， ClinicalTrials.gov
    Placebo control, 1.0ml BIOLOGICAL Phase PHASE1 Human Papillomavirus ClinicalTrials.gov
    HPV 16/18 vaccine, 1.0ml BIOLOGICAL Phase PHASE1 Human Papillomavirus ClinicalTrials.gov
    Placebo control, 0.5ml BIOLOGICAL Phase PHASE1 Human Papillomavirus ClinicalTrials.gov
    HPV 16/18 vaccine, 0,5ml BIOLOGICAL Phase PHASE1 Human Papillomavirus ClinicalTrials.gov
    vaccine made by Chengdu Institute of Biological Products BIOLOGICAL Phase PHASE3 Healthy ClinicalTrials.gov
    vaccine made by Beijing Minhai Biotechnology Co., Ltd BIOLOGICAL Phase PHASE3 Healthy ClinicalTrials.gov
    Crestor® DRUG Approved Hypercholesterolemia ClinicalTrials.gov
    Rosuvastatin DRUG Approved Hypercholesterolemia ClinicalTrials.gov
    Buccal insulin spray DRUG Preclinical Type 1 Diabetes Mellitus ClinicalTrials.gov
    Beraprost Sodium 314d Modified Release Tablets DRUG Phase PHASE3 Pulmonary Arterial Hypertension ClinicalTrials.gov
    Conventional therapy DRUG Phase PHASE1 Burns ClinicalTrials.gov
    CYT003-QbG10-placebo in combination with house dust mite allergen extract placebo DRUG Phase PHASE2 Perennial Allergic Rhinoconjunctivitis ClinicalTrials.gov
    CYT003-AllQbG10 in combination with house dust mite allergen extract placebo DRUG Phase PHASE2 Perennial Allergic Rhinoconjunctivitis ClinicalTrials.gov
    2.5IU/ml rabies vaccine （MRC-5 Cell) in humans(from 21-60 years old) BIOLOGICAL Phase PHASE1 Rabies ClinicalTrials.gov
    2.5IU/ml rabies vaccine （MRC-5 Cell) in humans(from 10-20 years old) BIOLOGICAL Phase PHASE1 Rabies ClinicalTrials.gov
    2.5IU/ml rabies vaccine （MRC-5 Cell) in humans aged 21-60 years old BIOLOGICAL Phase PHASE1 Rabies ClinicalTrials.gov
    2.5IU/ml in rabies vaccine （MRC-5 Cell) humans aged 10-20 years old BIOLOGICAL Phase PHASE1 Rabies ClinicalTrials.gov
    Coarse emulsion OTHER Approved Metabolic Diseases ClinicalTrials.gov
    Fine emulsion OTHER Approved Metabolic Diseases ClinicalTrials.gov
    Omalizumab DRUG Phase PHASE2 Allergic Asthma ClinicalTrials.gov
    No intervention OTHER Preclinical Maximal Rate of Fat Oxidation ClinicalTrials.gov
    cisplatinum DRUG Phase PHASE2 NSCLC ClinicalTrials.gov
    DC-CTL BIOLOGICAL Phase PHASE2 NSCLC ClinicalTrials.gov
    gemcitabine DRUG Phase PHASE2 NSCLC ClinicalTrials.gov
    vaccination PNEUMOVAX 23 BIOLOGICAL Phase PHASE3 Pneumococcal Infectious Diseases ClinicalTrials.gov
    vaccination PPV23 BIOLOGICAL Phase PHASE3 Pneumococcal Infectious Diseases ClinicalTrials.gov
    Hib Vaccine Group BIOLOGICAL Phase PHASE3 Meningitis ClinicalTrials.gov
    MCV-AC Vaccine Group BIOLOGICAL Phase PHASE3 Meningitis ClinicalTrials.gov
    MPV-A Vaccine Group BIOLOGICAL Phase PHASE3 Meningitis ClinicalTrials.gov
    MPV-ACYW135 Vaccine Group BIOLOGICAL Phase PHASE3 Meningitis ClinicalTrials.gov
    MCV-ACYW135 Vaccine Group BIOLOGICAL Phase PHASE3 Meningitis ClinicalTrials.gov
    TG-2349 as a new capsule formulation DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    TG-2349 as the original formulation DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Parthenon Broccoli OTHER Approved Cardiovascular Diseases ClinicalTrials.gov
    Beneforte broccoli OTHER Approved Cardiovascular Diseases ClinicalTrials.gov
    Intravenous DEVICE Phase PHASE1 Acute Spinal Cord Injury ClinicalTrials.gov
    Intrathecal DEVICE Phase PHASE1 Acute Spinal Cord Injury ClinicalTrials.gov
    Intradural space DEVICE Phase PHASE1 Acute Spinal Cord Injury ClinicalTrials.gov
    Laminectomy DEVICE Phase PHASE1 Acute Spinal Cord Injury ClinicalTrials.gov
    High carbonation OTHER Approved Glycemic Response ClinicalTrials.gov
    Low carbonation OTHER Approved Glycemic Response ClinicalTrials.gov
    No Carbonation OTHER Approved Glycemic Response ClinicalTrials.gov
    real-time ultrasonography (GE LOGIQ P5 ultrasound in CNRC) DEVICE Approved Diabetes ClinicalTrials.gov
    Chemotherapy DRUG Phase PHASE3 Metastatic Colorectal Cancer ClinicalTrials.gov
    APDC + Chemotherapy BIOLOGICAL Phase PHASE3 Metastatic Colorectal Cancer ClinicalTrials.gov
    Ag-D-CIK BIOLOGICAL Phase PHASE2 Gastric Cancer ClinicalTrials.gov
    Saline OTHER Phase PHASE1 Healthy ClinicalTrials.gov
    HAI-05 Influenza Vaccine BIOLOGICAL Phase PHASE1 Healthy ClinicalTrials.gov
    HAC1 Vaccine BIOLOGICAL Phase PHASE1 H1N1 Flu ClinicalTrials.gov
    Rice and Amino Acid mixtures OTHER Approved Metabolic Diseases ClinicalTrials.gov
    hAEC BIOLOGICAL Phase PHASE1 Bronchial Fistula ClinicalTrials.gov
    Consumption of a mixed meal OTHER Approved Inflammation ClinicalTrials.gov
    Radiotherapy RADIATION Phase PHASE2 Colorectal Cancer ClinicalTrials.gov
    DC-CIK BIOLOGICAL Phase PHASE2 Colorectal Cancer ClinicalTrials.gov
    MASCT BIOLOGICAL Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Apatinib DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Fasted Cohort PBT2 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Fed Cohort PBT2 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Questionnaires BEHAVIORAL Phase PHASE1 Chemotherapeutic Agent Toxicity ClinicalTrials.gov
    Anvirzel DRUG Phase PHASE1 Chemotherapeutic Agent Toxicity ClinicalTrials.gov
    Docetaxel DRUG Phase PHASE1 Chemotherapeutic Agent Toxicity ClinicalTrials.gov
    Carboplatin DRUG Phase PHASE1 Chemotherapeutic Agent Toxicity ClinicalTrials.gov
    DMARDs DRUG Phase PHASE1 Rheumatoid Arthritis ClinicalTrials.gov
    hUC-MSC + DMARDs BIOLOGICAL Phase PHASE1 Rheumatoid Arthritis ClinicalTrials.gov
    Act-HIB® BIOLOGICAL Phase PHASE3 Haemophilus Influenzae Type b Infections ClinicalTrials.gov
    Minhai-HIB BIOLOGICAL Phase PHASE3 Haemophilus Influenzae Type b Infections ClinicalTrials.gov
    inactivated quadrivalent influenza vaccine (split virion) BIOLOGICAL Phase PHASE1 Influenza ClinicalTrials.gov
    oral 14C-PBT2 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    IV PBT2 microtracer and oral PBT2 single dose DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Thick/150% Portion OTHER Approved Satiation ClinicalTrials.gov
    Thick/100% Portion OTHER Approved Satiation ClinicalTrials.gov
    Thin/150% Portion OTHER Approved Satiation ClinicalTrials.gov
    Thin/100% Portion OTHER Approved Satiation ClinicalTrials.gov
    CYT003 BIOLOGICAL Phase PHASE2 Moderate to Severe Allergic Asthma ClinicalTrials.gov
    Polydextrose OTHER Approved Obesity ClinicalTrials.gov
    Soy Protein OTHER Approved Obesity ClinicalTrials.gov
    SR-T100 gel with 2.3% of SM in Solanum undatum plant extract DRUG Phase EARLY_PHASE1 Vulvar Intraepithelial Neoplasia ClinicalTrials.gov
    GHB16L2 BIOLOGICAL Phase PHASE1 Influenza, Human ClinicalTrials.gov
    Sidaiyi® wound dressing DEVICE Approved Donor Site Wound ClinicalTrials.gov
    HQ® Matrix Medical Wound Dressing DEVICE Approved Donor Site Wound ClinicalTrials.gov
    New multicomponent "7H" intervention BEHAVIORAL Approved Frequent Attenders ClinicalTrials.gov
    SR-T100 ® Gel DRUG Phase PHASE2 Actinic Keratosis ClinicalTrials.gov
    CART20 BIOLOGICAL Phase PHASE1 Lymphoma, B-Cell ClinicalTrials.gov
    placebo (two doses) BIOLOGICAL Phase PHASE1 Ebola Virus Disease ClinicalTrials.gov
    placebo (one dose) BIOLOGICAL Phase PHASE1 Ebola Virus Disease ClinicalTrials.gov
    High dose Ebola Zaire vaccine (Ad5-EBOV) BIOLOGICAL Phase PHASE1 Ebola Virus Disease ClinicalTrials.gov
    Low dose Ebola Zaire vaccine (Ad5-EBOV) BIOLOGICAL Phase PHASE1 Ebola Virus Disease ClinicalTrials.gov
    Group C BIOLOGICAL Phase PHASE3 Meningitis ClinicalTrials.gov
    Group T BIOLOGICAL Phase PHASE3 Meningitis ClinicalTrials.gov
    autologous CSR T BIOLOGICAL Phase PHASE1 Recurrent PD-L1+ Malignant Tumors ClinicalTrials.gov
    Blood orange juice OTHER Approved Cardiovascular Disease ClinicalTrials.gov
    Standard (blonde) orange juice OTHER Approved Cardiovascular Disease ClinicalTrials.gov
    2.5IU/ml rabies vaccine(vero cell) in humans aged 51-60 years old BIOLOGICAL Phase PHASE3 Safety, Immunogenicity ClinicalTrials.gov
    2.5IU/ml rabies vaccine(vero cell) in humans aged 21-50 years old BIOLOGICAL Phase PHASE3 Safety, Immunogenicity ClinicalTrials.gov
    2.5IU/ml rabies vaccine(vero cell) in humans aged 10-20 years old BIOLOGICAL Phase PHASE3 Safety, Immunogenicity ClinicalTrials.gov
    2.5IU/ml rabies vaccine(MRC-5 cell) in humans aged 51-60 years old BIOLOGICAL Phase PHASE3 Safety, Immunogenicity ClinicalTrials.gov
    2.5IU/ml rabies vaccine(MRC-5 cell) in humans aged 21-50 years old BIOLOGICAL Phase PHASE3 Safety, Immunogenicity ClinicalTrials.gov
    2.5IU/ml rabies vaccine(MRC-5 cell) in humans aged 10-20 years old BIOLOGICAL Phase PHASE3 Safety, Immunogenicity ClinicalTrials.gov
    Thick/High Energy OTHER Approved Satiation ClinicalTrials.gov
    Thick/Low Energy OTHER Approved Satiation ClinicalTrials.gov
    Thin/High Energy OTHER Approved Satiation ClinicalTrials.gov
    Thin/Low Energy OTHER Approved Satiation ClinicalTrials.gov
    Trivalent influenza vaccine B BIOLOGICAL Phase PHASE3 Influenza ClinicalTrials.gov
    Trivalent influenza vaccine A BIOLOGICAL Phase PHASE3 Influenza ClinicalTrials.gov
    Quadrivalent influenza vaccine BIOLOGICAL Phase PHASE3 Influenza ClinicalTrials.gov
    SR-T100 gel DRUG Phase PHASE1 Actinic Keratosis ClinicalTrials.gov
    Psychosocial Intervention BEHAVIORAL Approved Depression ClinicalTrials.gov
    Vehicle gel DRUG Phase PHASE3 Actinic Keratosis ClinicalTrials.gov
    High/Low Glycaemic index test breakfast OTHER Approved Healthy ClinicalTrials.gov
    Isoquercetin plus Aspirin DRUG Approved Cardiovascular Disease ClinicalTrials.gov
    Aspirin DRUG Approved Cardiovascular Disease ClinicalTrials.gov
    Isoquercetin DRUG Approved Cardiovascular Disease ClinicalTrials.gov
    Vehicle control DRUG Approved Cardiovascular Disease ClinicalTrials.gov
    TG-2349 DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    1.6×10^11vp/2ml Ebola Zaire vaccine (Ad5-EBOV) BIOLOGICAL Phase PHASE1 Ebola Virus Disease ClinicalTrials.gov
    4×10^10vp/1ml Ebola Zaire vaccine (Ad5-EBOV) BIOLOGICAL Phase PHASE1 Ebola Virus Disease ClinicalTrials.gov
    anti-EGFRvIII CAR T cells BIOLOGICAL Phase PHASE1 Glioblastoma Multiforme ClinicalTrials.gov
    anti-mesothelin CAR T cells BIOLOGICAL Phase PHASE1 Mesothelin Positive Tumors ClinicalTrials.gov
    Diet monitoring OTHER Approved Inflammation ClinicalTrials.gov
    Activity monitoring OTHER Approved Inflammation ClinicalTrials.gov
    Calorie restriction OTHER Approved Inflammation ClinicalTrials.gov
    Low avenanthramide, medium phenolic acid OTHER Approved Healthy ClinicalTrials.gov
    High avenanthramide, phenolic acid OTHER Approved Healthy ClinicalTrials.gov
    UCMSC BIOLOGICAL Phase PHASE1 Bronchopleural Fistula ClinicalTrials.gov
    MASCT-I BIOLOGICAL Phase PHASE1 Solid Tumors ClinicalTrials.gov
    ULTRAPRO® Partially Absorbable Lightweight Mesh DEVICE Approved Inguinal Hernia ClinicalTrials.gov
    HQ® Matrix Soft Tissue Mesh DEVICE Approved Inguinal Hernia ClinicalTrials.gov
    Rice and bread (low GI) OTHER Approved Type 2 Diabetes ClinicalTrials.gov
    Rice and bread (high GI) OTHER Approved Type 2 Diabetes ClinicalTrials.gov
    CD8+NKG2D+ AKT Cell BIOLOGICAL Phase EARLY_PHASE1 Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    Transcatheter Arterial Chemoembolization (TACE) PROCEDURE Phase PHASE2 Hepatocellular Carcinoma ClinicalTrials.gov
    Anti-PD-L1 CSR T cells BIOLOGICAL Phase PHASE1 Glioblastoma Multiforme ClinicalTrials.gov
    Ebola Vaccine BIOLOGICAL Phase PHASE2 Ebola Disease ClinicalTrials.gov
    Recombinant hGM-CSF Herpes Simplex Virus Injection BIOLOGICAL Phase PHASE1 Melanoma ClinicalTrials.gov
    heat-treated fermented milk OTHER Approved Irritable Bowel Syndrome ClinicalTrials.gov
    LCA symbiotic fermented milk OTHER Approved Irritable Bowel Syndrome ClinicalTrials.gov
    Oxaliplatin DRUG Phase PHASE2 Gastric Cancer ClinicalTrials.gov
    Gimeracil and Oteracil Porassium Capsules DRUG Phase PHASE2 Gastric Cancer ClinicalTrials.gov
    autologous dendritic cells co-cultured with cytokine-induced killer cells BIOLOGICAL Phase PHASE2 Gastric Cancer ClinicalTrials.gov
    Cisplatin DRUG Phase PHASE2 Esophageal Neoplasms ClinicalTrials.gov
    Paclitaxel DRUG Phase PHASE2 Esophageal Neoplasms ClinicalTrials.gov
    PA83-FhCMB BIOLOGICAL Phase PHASE1 Anthrax ClinicalTrials.gov
    Protein Composition OTHER Approved Metabolic Disease ClinicalTrials.gov
    Meal (Eating) Frequency OTHER Approved Metabolic Disease ClinicalTrials.gov
    D-CIK BIOLOGICAL Phase PHASE1 Lung Cancer ClinicalTrials.gov
    [1-13C]leucine OTHER Approved Obesity ClinicalTrials.gov
    [2H5]phenylalanine OTHER Approved Obesity ClinicalTrials.gov
    Mixed Amino Acids DRUG Approved Obesity ClinicalTrials.gov
    Glucose DRUG Approved Obesity ClinicalTrials.gov
    Octreotide DRUG Approved Obesity ClinicalTrials.gov
    Insulin DRUG Approved Obesity ClinicalTrials.gov
    Pioglitazone DRUG Approved Obesity ClinicalTrials.gov
    Control Bread OTHER Approved Obesity ClinicalTrials.gov
    Negative energy balance BEHAVIORAL Approved Insulin Sensitivity ClinicalTrials.gov
    Congee and juice with sunflower oil OTHER Approved Glycaemic Response and Energy Balance ClinicalTrials.gov
    Congee and juice with sunflower gel OTHER Approved Glycaemic Response and Energy Balance ClinicalTrials.gov
    Congee and juice with coconut oil OTHER Approved Glycaemic Response and Energy Balance ClinicalTrials.gov
    Congee and juice with coconut gel OTHER Approved Glycaemic Response and Energy Balance ClinicalTrials.gov
    Prednisolone DRUG Phase PHASE2 Lupus Nephritis ClinicalTrials.gov
    Azathioprine DRUG Phase PHASE2 Lupus Nephritis ClinicalTrials.gov
    Mycophenolate mofetil DRUG Phase PHASE2 Lupus Nephritis ClinicalTrials.gov
    high glycaemic index intervention OTHER Approved Type 2 Diabetes ClinicalTrials.gov
    low glycaemic index intervention OTHER Approved Type 2 Diabetes ClinicalTrials.gov
    Methotrexate DRUG Phase PHASE1 Moderate and Severe Plaque Psoriasis ClinicalTrials.gov
    High-dose UC-MSCs BIOLOGICAL Phase PHASE1 Moderate and Severe Plaque Psoriasis ClinicalTrials.gov
    Low-dose UC-MSCs BIOLOGICAL Phase PHASE1 Moderate and Severe Plaque Psoriasis ClinicalTrials.gov
    biological amnion BIOLOGICAL Phase PHASE1 Asherman's Syndrome ClinicalTrials.gov
    hAECs BIOLOGICAL Phase PHASE1 Asherman's Syndrome ClinicalTrials.gov
    Peginterferon lambda BIOLOGICAL Phase PHASE1 Hepatitis C ClinicalTrials.gov
    Neo-MASCT BIOLOGICAL Phase PHASE1 NSCLC Stage IV ClinicalTrials.gov
    Neulasta® (pegfilgrastim) DRUG Phase PHASE2 Breast Cancer ClinicalTrials.gov
    F-627 DRUG Phase PHASE2 Breast Cancer ClinicalTrials.gov
    Regan Tangjiang DRUG Phase PHASE2 Cold ClinicalTrials.gov
    Breakfast with palm oil OTHER Approved Glucose Response ClinicalTrials.gov
    Breakfast with palm oil gel OTHER Approved Glucose Response ClinicalTrials.gov
    Breakfast with rice bran oil OTHER Approved Glucose Response ClinicalTrials.gov
    Breakfast with rice bran oil gel OTHER Approved Glucose Response ClinicalTrials.gov
    Placebo oral capsule DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Nemonoxacin 750Mg Capsule DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Moxifloxacin 400Mg Tablet DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Nemonoxacin 500Mg Capsule DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    CIK Cell BIOLOGICAL Phase PHASE1 Hepatocellular Carcinoma ClinicalTrials.gov
    Eccentric Exercise Training BEHAVIORAL Approved Healthy ClinicalTrials.gov
    Concentric Exercise Training BEHAVIORAL Approved Healthy ClinicalTrials.gov
    Neulastim DRUG Phase PHASE3 Breast Cancer Female ClinicalTrials.gov
    pegcyte DRUG Phase PHASE3 Breast Cancer Female ClinicalTrials.gov
    BCMA CAR-T Cells BIOLOGICAL Phase EARLY_PHASE1 Relapsed and Refractory Multiple Myeloma ClinicalTrials.gov
    High GI Dinner OTHER Approved Healthy ClinicalTrials.gov
    Low GI Dinner OTHER Approved Healthy ClinicalTrials.gov
    High GI Breakfast OTHER Approved Healthy ClinicalTrials.gov
    Low GI Breakfast OTHER Approved Healthy ClinicalTrials.gov
    BCMA nanobody CAR-T cells DRUG Phase PHASE1 Relapsed/Refractory Myeloma ClinicalTrials.gov
    BCMA CAR-T BIOLOGICAL Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Compound betamethasone DRUG Phase PHASE2 Rotator Cuff Tear ClinicalTrials.gov
    Autologous adipose-derived MSCs BIOLOGICAL Phase PHASE2 Rotator Cuff Tear ClinicalTrials.gov
    OrienX010 BIOLOGICAL Preclinical Melanoma ClinicalTrials.gov
    CAR19 T cells carrying cytoplasmic activated PD-1 DRUG Phase PHASE1 Relapsed Non Hodgkin Lymphoma ClinicalTrials.gov
    Sucrose OTHER Approved Diabetes Mellitus ClinicalTrials.gov
    Isomaltulose OTHER Approved Diabetes Mellitus ClinicalTrials.gov
    EGFR IL12 CART BIOLOGICAL Phase PHASE1 Metastatic Colorectal Cancer ClinicalTrials.gov
    Live-Attenuated influenza Vaccine(LAIV) BIOLOGICAL Phase PHASE3 Influenza ClinicalTrials.gov
    Minimally invasive implantation PROCEDURE Approved Premature Ovarian Failure ClinicalTrials.gov
    CD19 CAR-T BIOLOGICAL Phase PHASE1 B-cell Acute Lymphocytic Leukemia ClinicalTrials.gov
    Standard of Care (SoC) OTHER Phase PHASE4 Hemostasis ClinicalTrials.gov
    Bioseal Fibrin Sealant BIOLOGICAL Phase PHASE4 Hemostasis ClinicalTrials.gov
    Treprostinil sodium for inhalation DRUG Phase PHASE2 Idiopathic Pulmonary Fibrosis ClinicalTrials.gov
    Low glycaemic index meal and rest OTHER Approved Glycaemic Response ClinicalTrials.gov
    Low glycaemic index meal and exercise OTHER Approved Glycaemic Response ClinicalTrials.gov
    High glycaemic index meal and rest OTHER Approved Glycaemic Response ClinicalTrials.gov
    High glycaemic index meal and exercise OTHER Approved Glycaemic Response ClinicalTrials.gov
    Fludarabine and cyclophosphamide DRUG Phase PHASE1 Relapsed or Refractory B-cell Lymphoma ClinicalTrials.gov
    iPD1 CD19 eCAR T cells BIOLOGICAL Phase PHASE1 Relapsed or Refractory B-cell Lymphoma ClinicalTrials.gov
    Standard Polysomnography (PSG) OTHER Approved Obstructive Sleep Apnea (OSA) ClinicalTrials.gov
    Home Respiratory Polygraphy (APNIA) OTHER Approved Obstructive Sleep Apnea (OSA) ClinicalTrials.gov
    Pfs25 VLP- FhCMB BIOLOGICAL Phase PHASE1 Malaria ClinicalTrials.gov
    Recombinant human Apo-2 ligand for Injection BIOLOGICAL Phase PHASE3 Non-small-cell Lung Cancer (NSCLC) Stage IV ClinicalTrials.gov
    Filgrastim BIOLOGICAL Phase PHASE2 Neutropenia ClinicalTrials.gov
    anti-CD19/BCMA CAR-T cells BIOLOGICAL Phase PHASE1 Multiple Myeloma in Relapse ClinicalTrials.gov
    Placebos DRUG Phase PHASE1 Healthy Adults ClinicalTrials.gov
    LY06006 DRUG Phase PHASE1 Healthy Adults ClinicalTrials.gov
    human amniotic epithelial cells BIOLOGICAL Phase PHASE1 Spastic Cerebral Palsy ClinicalTrials.gov
    Breakfast, lunch, snack and dinner OTHER Approved Type 2 Diabetes, Obesity, Prediabetes ClinicalTrials.gov
    natural killer and natural killer T cell BIOLOGICAL Phase PHASE1 Non-small Cell Lung Cancer ClinicalTrials.gov
    Ultrasound-guided Compound betamethasone injection DRUG Phase PHASE2 Rotator Cuff Tear ClinicalTrials.gov
    Ultrasound-guided platelet-rich-plasma (PRP) injection BIOLOGICAL Phase PHASE2 Rotator Cuff Tear ClinicalTrials.gov
    Ultrasound-guided pure platelet-rich-plasma (P-PRP) injection BIOLOGICAL Phase PHASE2 Rotator Cuff Tear ClinicalTrials.gov
    Rice with vegetables and high spice OTHER Approved Cardiometabolic Risk ClinicalTrials.gov
    Rice with vegetables and low spice OTHER Approved Cardiometabolic Risk ClinicalTrials.gov
    Rice with tomatoes and peeled aubergine (no spice) OTHER Approved Cardiometabolic Risk ClinicalTrials.gov
    PMR 200 mg DRUG Phase PHASE1 Intermittent Claudication ClinicalTrials.gov
    PMR 150 mg DRUG Phase PHASE1 Intermittent Claudication ClinicalTrials.gov
    Cilostazol 100 mg DRUG Phase PHASE1 Intermittent Claudication ClinicalTrials.gov
    Porridge and juice with coconut oil gel OTHER Approved Diabetes ClinicalTrials.gov
    Porridge and juice with coconut oil OTHER Approved Diabetes ClinicalTrials.gov
    Glucose with grass jelly (solid) OTHER Approved Diabetes ClinicalTrials.gov
    Glucose with grass jelly solution OTHER Approved Diabetes ClinicalTrials.gov
    Circulating tumor cells DEVICE Phase PHASE3 Circulating Tumor Cells.Breast ClinicalTrials.gov
    Alginate bread OTHER Approved Obesity ClinicalTrials.gov
    amniotic epithelial cells BIOLOGICAL Phase PHASE1 HAM ClinicalTrials.gov
    NK cells BIOLOGICAL Phase PHASE1 HAM ClinicalTrials.gov
    Pegfilgrastim DRUG Phase PHASE1 Breast Cancer ClinicalTrials.gov
    debridement PROCEDURE Phase PHASE1 Nonunion Fracture ClinicalTrials.gov
    Nemonoxacin 3 tablets DRUG Phase PHASE2 Community-acquired Pneumonia ClinicalTrials.gov
    Levofloxacin 500 mg placebol DRUG Phase PHASE2 Community-acquired Pneumonia ClinicalTrials.gov
    Low Glycemic Index OTHER Approved Pre Diabetes ClinicalTrials.gov
    High Glycemic Index OTHER Approved Pre Diabetes ClinicalTrials.gov
    SCB01A DRUG Phase PHASE1 Solid Tumors ClinicalTrials.gov
    HPV vaccine BIOLOGICAL Phase PHASE1 HPV Infections ClinicalTrials.gov
    Heberprot P BIOLOGICAL Preclinical Diabetic Foot ClinicalTrials.gov
    Manual Compression OTHER Phase PHASE4 Cardiovascular Bleeding ClinicalTrials.gov
    Recombinant Anti-CD19m-CD3 Antibody Injection BIOLOGICAL Phase PHASE1 Relapsed or Refractory B-cell Lymphoma ClinicalTrials.gov
    Pemetrexed and donor-derived NK cell infusion BIOLOGICAL Phase PHASE1 Non-small Cell Lung Cancer ClinicalTrials.gov
    TM4SF1- and EpCAM-positive chimeric antigen receptor T-cell therapy BIOLOGICAL Approved Advanced Solid Tumor ClinicalTrials.gov
    Cell infusion for Extended research (Group B) OTHER Approved Advanced Gastric Cancer ClinicalTrials.gov
    Cell infusion for Dose-finding (Group A) OTHER Approved Advanced Gastric Cancer ClinicalTrials.gov
    Soybean milk OTHER Approved Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Ricebran soybean milk OTHER Approved Diabetes Mellitus, Type 2 ClinicalTrials.gov
    anti-CD19 CAR-T BIOLOGICAL Phase PHASE1 B-cell Adult Acute Lymphoblastic Leukemia ClinicalTrials.gov
    anti-MESO CAR-T cells BIOLOGICAL Phase EARLY_PHASE1 Ovarian Cancer ClinicalTrials.gov
    Biscuit 2 Test OTHER Approved Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Biscuit 1 Control OTHER Approved Diabetes Mellitus, Type 2 ClinicalTrials.gov
    UC-MSCs BIOLOGICAL Phase PHASE1 COVID-19 ClinicalTrials.gov
    Stem cells from human exfoliated teeth BIOLOGICAL Phase EARLY_PHASE1 Type1diabetes ClinicalTrials.gov
    Life information rehabilitation therapy DRUG Phase PHASE2 Liver, Cancer of, Non-Resectable ClinicalTrials.gov
    Cancer ablation DEVICE Phase PHASE2 Liver, Cancer of, Non-Resectable ClinicalTrials.gov
    SR-T100 gel with 2.3% SM DRUG Phase PHASE2 Condyloma Acuminata ClinicalTrials.gov
    SR-T100 gel with 1.0 % SM DRUG Phase PHASE2 Condyloma Acuminata ClinicalTrials.gov
    Dacarbazine (DTIC) DRUG Phase PHASE2 Melanoma (Skin) ClinicalTrials.gov
    OrienX010 injection BIOLOGICAL Phase PHASE2 Melanoma (Skin) ClinicalTrials.gov
    Humanized CD19 CAR-T cells DRUG Phase EARLY_PHASE1 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    BCMA/CD19 Dual-Target CAR-T BIOLOGICAL Phase EARLY_PHASE1 Multiple Myeloma ClinicalTrials.gov
    Anyu Peibo DRUG Phase PHASE3 Major Depressive Disorder ClinicalTrials.gov
    BM-MSCs BIOLOGICAL Phase PHASE1 Coronavirus Disease 2019 (COVID-19) ClinicalTrials.gov
    Food sequence 5 OTHER Approved Diabetes Mellitus ClinicalTrials.gov
    Food sequence 4 OTHER Approved Diabetes Mellitus ClinicalTrials.gov
    Food sequence 3 OTHER Approved Diabetes Mellitus ClinicalTrials.gov
    Food sequence 2 OTHER Approved Diabetes Mellitus ClinicalTrials.gov
    Food sequence 1 OTHER Approved Diabetes Mellitus ClinicalTrials.gov
    neoantigen vaccine + anti-angioge DRUG Phase PHASE1 Non Small Cell Lung Cancer ClinicalTrials.gov
    neoantigen vaccine + EGFR-TKI DRUG Phase PHASE1 Non Small Cell Lung Cancer ClinicalTrials.gov
    Tumor Electric Fields Treatment System DEVICE Phase EARLY_PHASE1 Glioblastoma ClinicalTrials.gov
    EBV-TCR-T (YT-E001) cells BIOLOGICAL Phase PHASE2 Nasopharyngeal Carcinoma ClinicalTrials.gov
    anti-CD19/CD22 CAR-T cells BIOLOGICAL Phase PHASE1 CD19-positive ALL ClinicalTrials.gov
    Sintilimab Injection DRUG Phase PHASE1 Gastric Cancer ClinicalTrials.gov
    CTL BIOLOGICAL Phase PHASE1 Gastric Cancer ClinicalTrials.gov
    DC vaccine BIOLOGICAL Phase PHASE1 Gastric Cancer ClinicalTrials.gov
    haploid allogeneic NK cell therapy BIOLOGICAL Phase EARLY_PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Bake beans in tomato sauce, low GI OTHER Approved Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Bake beans in tomato sauce, reduced sugar OTHER Approved Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Regular Bake beans in tomato sauce OTHER Approved Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Glucose reference 3 OTHER Approved Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Glucose Reference 2 OTHER Approved Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Glucose Reference 1 OTHER Approved Diabetes Mellitus, Type 2 ClinicalTrials.gov
    CD19/CD20 bispecific CAR-T cells BIOLOGICAL Phase PHASE1 B-Cell Lymphoma Stage I ClinicalTrials.gov
    Tumor infiltrating lymphocyte DRUG Phase PHASE1 Hepatic Carcinoma ClinicalTrials.gov
    Individualized neoantigen peptides vaccine DRUG Phase PHASE1 Non Small Cell Lung Cancer ClinicalTrials.gov
    Sodium Hyaluronate DRUG Phase EARLY_PHASE1 Knee Osteoarthritis ClinicalTrials.gov
    High Dose of Mesenchymal stem cell BIOLOGICAL Phase EARLY_PHASE1 Knee Osteoarthritis ClinicalTrials.gov
    Low Dose of Mesenchymal stem cell BIOLOGICAL Phase EARLY_PHASE1 Knee Osteoarthritis ClinicalTrials.gov
    Dental pulp mesenchymal stem cells BIOLOGICAL Phase EARLY_PHASE1 COVID-19 ClinicalTrials.gov
    Meningococcal Group ACYW135 Conjugate Vaccine BIOLOGICAL Phase PHASE1 Meningococcal Infections ClinicalTrials.gov
    Prevnar 13 BIOLOGICAL Phase PHASE3 Pneumonia ClinicalTrials.gov
    13-valent pneumococcal conjugate vaccine BIOLOGICAL Phase PHASE3 Pneumonia ClinicalTrials.gov
    Bioseal BIOLOGICAL Phase PHASE3 Benign Tumors ClinicalTrials.gov
    Product Labelling and Sensory modifications BEHAVIORAL Approved Markedly Reduced Food Intake ClinicalTrials.gov
    CD19 UCARTcells BIOLOGICAL Phase EARLY_PHASE1 B-cell Acute Lymphoblastic Leukemia (B-ALL) ClinicalTrials.gov
    G-CSF DRUG Phase PHASE1 Prostate Cancer ClinicalTrials.gov
    Burixafor Hydrobromide DRUG Phase PHASE1 Prostate Cancer ClinicalTrials.gov
    autologous anti-CD19 CAR T cells BIOLOGICAL Phase PHASE1 B-cell Lymphoma ClinicalTrials.gov
    Anti-CD30 CAR T cells GENETIC Phase PHASE1 Adult T-Cell Lymphoma/Leukaemia ClinicalTrials.gov
    CD20 CAR-T BIOLOGICAL Phase EARLY_PHASE1 Relapsed and Refractory B Cell Lymphoma ClinicalTrials.gov
    Allogeneic MPBC transplantation from matched related donor BIOLOGICAL Phase PHASE1 Hematological Malignancies ClinicalTrials.gov
    Isomaltulose Jelly OTHER Approved Diabetes ClinicalTrials.gov
    Sucrose Jelly OTHER Approved Diabetes ClinicalTrials.gov
    Rice Roll with resistant starch OTHER Approved Diabetes ClinicalTrials.gov
    Rice Roll OTHER Approved Diabetes ClinicalTrials.gov
    Beta-glucan yellow Noodle OTHER Approved Diabetes ClinicalTrials.gov
    Wheat Yellow Noodle OTHER Approved Diabetes ClinicalTrials.gov
    CD22 CAR-T BIOLOGICAL Approved B-ALL ClinicalTrials.gov
    XYF19 CAR-T cell GENETIC Phase PHASE1 Leukemia Lymphocytic Acute (ALL) in Relapse ClinicalTrials.gov
    allogeneic hematopoietic cell transplantation PROCEDURE Preclinical Acute Myeloid Leukemia ClinicalTrials.gov
    Autologous CAR-T cells BIOLOGICAL Phase PHASE1 Leukemia ClinicalTrials.gov
    BCMA/CD19 dual-target CAR-T cell immunotherapy BIOLOGICAL Phase EARLY_PHASE1 Multiple Myeloma ClinicalTrials.gov
    CD19.CAR-T cells DRUG Phase PHASE1 Recurrent Adult Diffuse Large Cell Lymphoma ClinicalTrials.gov
    GC022F BIOLOGICAL Phase EARLY_PHASE1 B-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Jenscare TAVI DEVICE Approved Severe Aortic Stenosis ClinicalTrials.gov
    Xgeva 120 MG in 1.7 ML Injection DRUG Phase PHASE1 Healthy Adults ClinicalTrials.gov
    LY01011 DRUG Phase PHASE1 Healthy Adults ClinicalTrials.gov
    Commercialized IPV BIOLOGICAL Phase PHASE1 Polio ClinicalTrials.gov
    Commercialized sIPV BIOLOGICAL Phase PHASE1 Polio ClinicalTrials.gov
    GC022 BIOLOGICAL Phase EARLY_PHASE1 B-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Resistance exercise OTHER Approved Muscle Loss ClinicalTrials.gov
    Blood draw PROCEDURE Preclinical Bipolar Disorder ClinicalTrials.gov
    Psychiatric Questionnaires PROCEDURE Preclinical Bipolar Disorder ClinicalTrials.gov
    non intervational OTHER Preclinical Acute Myelogenous Leukemia (AML) ClinicalTrials.gov
    Cold water OTHER Approved Energy Expenditure ClinicalTrials.gov
    Cold air OTHER Approved Energy Expenditure ClinicalTrials.gov
    Oat OTHER Approved Healthy ClinicalTrials.gov
    PLB1003 DRUG Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    CD20/CD22 dual Targeted CAR T-cells DRUG Phase EARLY_PHASE1 Relapsed and Refractory ClinicalTrials.gov
    Eylea DRUG Phase PHASE3 Age Related Macular Degeneration ClinicalTrials.gov
    LY09004 DRUG Phase PHASE3 Age Related Macular Degeneration ClinicalTrials.gov
    CAR-T cells BIOLOGICAL Phase PHASE1 Refractory ClinicalTrials.gov
    SR-T100 with 2.3% of SM DRUG Phase PHASE2 Actinic Keratosis ClinicalTrials.gov
    No-Exercise and Meal (NEX) BEHAVIORAL Approved Obesity ClinicalTrials.gov
    Exercise and Meal (EX) BEHAVIORAL Approved Obesity ClinicalTrials.gov
    PD-1 Knockout T Cells OTHER Approved Esophageal Cancer ClinicalTrials.gov
    Educational intervention BEHAVIORAL Approved Performance ClinicalTrials.gov
    Rice with beancurd OTHER Approved Metabolic Diseases ClinicalTrials.gov
    Rice with egg white OTHER Approved Metabolic Diseases ClinicalTrials.gov
    Rice with fish OTHER Approved Metabolic Diseases ClinicalTrials.gov
    Rice with chicken breast OTHER Approved Metabolic Diseases ClinicalTrials.gov
    White rice OTHER Approved Metabolic Diseases ClinicalTrials.gov
    Third-generation anti-CD123 CAR-T cells BIOLOGICAL Phase PHASE1 CD123+ Acute Myeloid Leukemia ClinicalTrials.gov
    Esuberaprost DRUG Phase PHASE3 Pulmonary Arterial Hypertension ClinicalTrials.gov
    Third generation CAR-T cells GENETIC Phase PHASE1 B Cell Lymphoma ClinicalTrials.gov
    LPM3480226 DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    εPA-44 BIOLOGICAL Phase PHASE2 Chronic Hepatitis B ClinicalTrials.gov
    JWCAR029 BIOLOGICAL Phase PHASE1 Non Hodgkin Lymphoma ClinicalTrials.gov
    Anti-BCMA CAR-T cells BIOLOGICAL Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Beraprost Sodium Modified Release DRUG Phase PHASE2 Pulmonary Arterial Hypertension ClinicalTrials.gov
    SHED group BIOLOGICAL Phase EARLY_PHASE1 Liver Cirrhosis ClinicalTrials.gov
    F-627 320 μg/kg BIOLOGICAL Phase PHASE1 Neutropenia ClinicalTrials.gov
    F-627 240 μg/kg BIOLOGICAL Phase PHASE1 Neutropenia ClinicalTrials.gov
    Three-dose regimen of commercialized IPV BIOLOGICAL Phase PHASE2 Polio and Post-Polio Syndrome ClinicalTrials.gov
    Three-dose regimen of commercialized sIPV BIOLOGICAL Phase PHASE2 Polio and Post-Polio Syndrome ClinicalTrials.gov
    Three-dose regimen of low dosage investigational sIPV BIOLOGICAL Phase PHASE2 Polio and Post-Polio Syndrome ClinicalTrials.gov
    Three-dose regimen of medium dosage investigational sIPV BIOLOGICAL Phase PHASE2 Polio and Post-Polio Syndrome ClinicalTrials.gov
    Three-dose regimen of high dosage investigational sIPV BIOLOGICAL Phase PHASE2 Polio and Post-Polio Syndrome ClinicalTrials.gov
    CD123 CAR-T cells BIOLOGICAL Phase PHASE1 Acute Myelocytic Leukemia ClinicalTrials.gov
    Irinotecan-only and sequential-CMAB009 DRUG Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    CMAB009 plus Irinotecan DRUG Phase PHASE2 Metastatic Colorectal Cancer ClinicalTrials.gov
    Meat reduction BEHAVIORAL Approved Lipidemia ClinicalTrials.gov
    Interleukin-12 DRUG Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Dendritic Cell/Tumor Fusion Vaccine BIOLOGICAL Phase PHASE1 Glioblastoma ClinicalTrials.gov
    DR. Chip HPV genotyping IVD kit DEVICE Approved Cervical Intraepithelial Neoplasia ClinicalTrials.gov
    entecavir DRUG Phase PHASE2 Chronic Hepatitis B ClinicalTrials.gov
    Therapeutic HBV vaccine BIOLOGICAL Phase PHASE2 Chronic Hepatitis B ClinicalTrials.gov
    Human CD19 targeted T Cells Injection DRUG Phase PHASE1 CD19-positive ClinicalTrials.gov
    20 % Polished rice OTHER Approved Diabetes Mellitus ClinicalTrials.gov
    9 % polished rice OTHER Approved Diabetes Mellitus ClinicalTrials.gov
    6 % polished rice OTHER Approved Diabetes Mellitus ClinicalTrials.gov
    3 % polished rice OTHER Approved Diabetes Mellitus ClinicalTrials.gov
    Brown Rice OTHER Approved Diabetes Mellitus ClinicalTrials.gov
    LY-CovMab DRUG Phase PHASE1 Covid19 ClinicalTrials.gov
    LY011 BIOLOGICAL Phase EARLY_PHASE1 Advanced Gastric Adenocarcinoma ClinicalTrials.gov
    anti- MESO CAR-T cells DRUG Phase EARLY_PHASE1 Ovarian Cancer ClinicalTrials.gov
    Senl-h19 CAR-T BIOLOGICAL Approved B-ALL ClinicalTrials.gov
    Leukapheresis PROCEDURE Approved Hodgkin's Lymphoma ClinicalTrials.gov
    Cyclophosphamide,Fludarabine DRUG Approved Hodgkin's Lymphoma ClinicalTrials.gov
    Auto CAR-T BIOLOGICAL Approved Hodgkin's Lymphoma ClinicalTrials.gov
    SARS-CoV-2 Vaccine (Vero Cells), Inactivated BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    CD 19+22 DRUG Phase EARLY_PHASE1 Childhood Acute Lymphoblastic Leukemia ClinicalTrials.gov
    TG-1000 DRUG Phase PHASE1 Healthy Chinese Volunteers ClinicalTrials.gov
    Immune inhibitors DRUG Phase EARLY_PHASE1 Multiple Myeloma ClinicalTrials.gov
    Bravelle DRUG Phase PHASE1 Female Infertility ClinicalTrials.gov
    Gonal-f DRUG Phase PHASE1 Female Infertility ClinicalTrials.gov
    FSH-GEX™ DRUG Phase PHASE1 Female Infertility ClinicalTrials.gov
    High Myopic Posterior Scleral Fixation System DEVICE Approved High Myopia ClinicalTrials.gov
    coconut oil-water emulsion OTHER Approved Carotenoids ClinicalTrials.gov
    coconut oil-water mixture OTHER Approved Carotenoids ClinicalTrials.gov
    olive oil-water emulsion OTHER Approved Carotenoids ClinicalTrials.gov
    olive oil-water mixture OTHER Approved Carotenoids ClinicalTrials.gov
    ctDNA multi-omics test DEVICE Preclinical Gastric Cancer ClinicalTrials.gov
    Prolia DRUG Phase PHASE1 Healthy Adults ClinicalTrials.gov
    BCMA Targeted CAR T-cells DRUG Phase EARLY_PHASE1 Relapse Multiple Myeloma ClinicalTrials.gov
    CS1 Targeted CAR T-cells DRUG Phase EARLY_PHASE1 Relapse Multiple Myeloma ClinicalTrials.gov
    ZD03 DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Low Protein OTHER Approved Metabolic Flexibility ClinicalTrials.gov
    GC022F CAR-T cells DRUG Phase PHASE1 Relapsed and Refractory ClinicalTrials.gov
    TrasGEX™ DRUG Phase PHASE1 Solid Tumors ClinicalTrials.gov
    CD19+CD22 CAR-T DRUG Phase EARLY_PHASE1 Adult B Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Artesunate-amodiaquine drug combination DRUG Phase PHASE4 Falciparum Malaria ClinicalTrials.gov
    Live Attenuated Influenza Vaccine placebo BIOLOGICAL Phase PHASE1 Influenza Prevention ClinicalTrials.gov
    Live Attenuated Influenza Vaccine BIOLOGICAL Phase PHASE1 Influenza Prevention ClinicalTrials.gov
    Tamarind Drink OTHER Approved Metabolic Disease ClinicalTrials.gov
    Tamarind Rice OTHER Approved Metabolic Disease ClinicalTrials.gov
    Cornsilk Drink (High dose) OTHER Approved Metabolic Disease ClinicalTrials.gov
    Cornsilk Drink (Low dose) OTHER Approved Metabolic Disease ClinicalTrials.gov
    Cornsilk Rice (High dose) OTHER Approved Metabolic Disease ClinicalTrials.gov
    Cornsilk Rice (Low dose) OTHER Approved Metabolic Disease ClinicalTrials.gov
    Cumin Drink OTHER Approved Metabolic Disease ClinicalTrials.gov
    Cumin Rice OTHER Approved Metabolic Disease ClinicalTrials.gov
    CD7 CAR-T BIOLOGICAL Phase PHASE1 T-cell Acute Lymphoblastic Leukemia/Lymphoma ClinicalTrials.gov
    Test 5 OTHER Approved Healthy ClinicalTrials.gov
    Test 4 OTHER Approved Healthy ClinicalTrials.gov
    Test 3 OTHER Approved Healthy ClinicalTrials.gov
    Test 2 OTHER Approved Healthy ClinicalTrials.gov
    Test 1 OTHER Approved Healthy ClinicalTrials.gov
    high dosage inactivated SARS-CoV-2 vaccine BIOLOGICAL Phase PHASE1 COVID-19 ClinicalTrials.gov
    medium dosage inactivated SARS-CoV-2 vaccine BIOLOGICAL Phase PHASE1 COVID-19 ClinicalTrials.gov
    EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19) BIOLOGICAL Phase PHASE3 Covid19 ClinicalTrials.gov
    urinary FSH DRUG Phase PHASE1 Female Infertility ClinicalTrials.gov
    recombinant FSH DRUG Phase PHASE1 Female Infertility ClinicalTrials.gov
    individualized diet BEHAVIORAL Phase PHASE2 NAFLD ClinicalTrials.gov
    CD79b CAR-T Cells DRUG Phase EARLY_PHASE1 Relapsed and/or Refractory Acute Lymphoblastic Leukemia ClinicalTrials.gov
    CAR-γδT BIOLOGICAL Approved AML ClinicalTrials.gov
    Human BCMA targeted T Cells Injection DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    hAESCs BIOLOGICAL Phase EARLY_PHASE1 Intrauterine Adhesion ClinicalTrials.gov
    Autologous CD19-targeting CAR T cells BIOLOGICAL Phase PHASE1 Acute Lymphocytic Leukemia ClinicalTrials.gov
    Nasal Spray Lyophilized Live Attenuated Influenza Vaccine BIOLOGICAL Approved Randomized ClinicalTrials.gov
    Cyclophosphamide, fludarabine DRUG Phase EARLY_PHASE1 CD5+ Relapsed/Refractory Hematopoietic Malignancies ClinicalTrials.gov
    CT125A cells BIOLOGICAL Phase EARLY_PHASE1 CD5+ Relapsed/Refractory Hematopoietic Malignancies ClinicalTrials.gov
    IL3 CAR T-cells DRUG Phase EARLY_PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Adoptive TKC transfer therapy BIOLOGICAL Phase PHASE1 Advanced Non-small Cell Lung Cancer ClinicalTrials.gov
    CD19 CAR T BIOLOGICAL Phase PHASE1 B-cell Malignancy ClinicalTrials.gov
    BPS-314d-MR DRUG Phase PHASE2 Pulmonary Arterial Hypertension ClinicalTrials.gov
    CAR-T cells targeting CD19 and CD22 DRUG Phase PHASE1 B-Cell Acute Lymphoblastic Leukemia, Adult ClinicalTrials.gov
    GC019F BIOLOGICAL Phase PHASE1 B-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    KMRC011 25μg or Placebo DRUG Phase PHASE1 Acute Radiation Syndrome ClinicalTrials.gov
    KMRC011 20μg or Placebo DRUG Phase PHASE1 Acute Radiation Syndrome ClinicalTrials.gov
    KMRC011 15μg or Placebo DRUG Phase PHASE1 Acute Radiation Syndrome ClinicalTrials.gov
    KMRC011 10μg or Placebo DRUG Phase PHASE1 Acute Radiation Syndrome ClinicalTrials.gov
    KMRC011 5μg or Placebo DRUG Phase PHASE1 Acute Radiation Syndrome ClinicalTrials.gov
    Systemic Corticosteroids DRUG Phase PHASE1 Acute Graft vs Host Disease ClinicalTrials.gov
    Recombinant Human Interleukin-22 IgG2-Fc (F-652) DRUG Phase PHASE1 Acute Graft vs Host Disease ClinicalTrials.gov
    OsrHSA 200 mg/kg IV DRUG Phase PHASE1 Ascites Hepatic ClinicalTrials.gov
    OsrHSA 140 mg/kg IV DRUG Phase PHASE1 Ascites Hepatic ClinicalTrials.gov
    OsrHSA 80 mg/kg IV DRUG Phase PHASE1 Ascites Hepatic ClinicalTrials.gov
    OsrHSA 40 mg/kg IV DRUG Phase PHASE1 Ascites Hepatic ClinicalTrials.gov
    OsrHSA 20 mg/kg IV DRUG Phase PHASE1 Ascites Hepatic ClinicalTrials.gov
    Mist-fan cooling OTHER Approved Hyperthermia ClinicalTrials.gov
    Forearm cooling DEVICE Approved Hyperthermia ClinicalTrials.gov
    personalized vaccine BIOLOGICAL Phase PHASE1 Malignant Glioma ClinicalTrials.gov
    Murine CD19 CAR-T cells DRUG Phase EARLY_PHASE1 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Assigned Interventions CD19/BCMA CAR T-cells BIOLOGICAL Phase EARLY_PHASE1 Systemic Lupus Erythematosus ClinicalTrials.gov
    13-valent pneumococcal polysaccharide conjugate vaccine BIOLOGICAL Phase PHASE3 Diseases Caused by Streptococcus Pneumoniae Serotypes ClinicalTrials.gov
    7-valent pneumococcal conjugate vaccine BIOLOGICAL Phase PHASE3 Diseases Caused by Streptococcus Pneumoniae Serotypes ClinicalTrials.gov
    LMP1 CAR T-cells DRUG Phase EARLY_PHASE1 Infectious Diseases ClinicalTrials.gov
    CD19/BCMA Targeted CAR T-cells DRUG Phase EARLY_PHASE1 Multiple Myeloma in Relapse ClinicalTrials.gov
    CD19/BCMA Targeted CAR T-cells and dasatinib DRUG Phase EARLY_PHASE1 Multiple Myeloma in Relapse ClinicalTrials.gov
    Nanocovax BIOLOGICAL Phase PHASE1 COVID-19 ClinicalTrials.gov
    NKG2D CAR T-cells DRUG Phase EARLY_PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells DRUG Phase PHASE1 Acute Lymphocytic Leukemia ClinicalTrials.gov
    CRV 101 BIOLOGICAL Phase PHASE1 Herpes Zoster ClinicalTrials.gov
    MATFILL (PTFE) DEVICE Approved Edentulous Alveolar Ridge ClinicalTrials.gov
    IV infusion of placebo GENETIC Phase PHASE1 Stroke ClinicalTrials.gov
    Autologous EPCs transplantation GENETIC Phase PHASE1 Stroke ClinicalTrials.gov
    Autologous BMSCs transplantation GENETIC Phase PHASE1 Stroke ClinicalTrials.gov
    calcium phosphate ceramic DEVICE Approved Sinus Floor Augmentation ClinicalTrials.gov
    Bio-Oss DEVICE Approved Sinus Floor Augmentation ClinicalTrials.gov
    Sal seed oleogel OTHER Approved Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Sal seed oil OTHER Approved Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Cocoa butter oleogel OTHER Approved Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Cocoa butter OTHER Approved Diabetes Mellitus, Type 2 ClinicalTrials.gov
    Autologous aPD-L1 armored anti-CD22 CAR T cells BIOLOGICAL Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    Orcinoside DRUG Phase PHASE2 Major Depressive Disorder (MDD) ClinicalTrials.gov
    CSTC1 Matched vehicle DRUG Phase PHASE2 Diabetic Foot Ulcer ClinicalTrials.gov
    CSTC1 DRUG Phase PHASE2 Diabetic Foot Ulcer ClinicalTrials.gov
    diet assessment OTHER Approved GERD in Children ClinicalTrials.gov
    Sucrose/Isomaltulose 80:20 OTHER Approved Type 2 Diabetes ClinicalTrials.gov
    Sucrose/Isomaltulose 70:30 OTHER Approved Type 2 Diabetes ClinicalTrials.gov
    Sucrose/Isomaltulose 60:40 OTHER Approved Type 2 Diabetes ClinicalTrials.gov
    Sucrose/Isomaltulose 50:50 OTHER Approved Type 2 Diabetes ClinicalTrials.gov
    Sucrose/Isomaltulose 0:100 OTHER Approved Type 2 Diabetes ClinicalTrials.gov
    Sucrose/Isomaltulose 100:0 OTHER Approved Type 2 Diabetes ClinicalTrials.gov
    Glucose Solution 3 OTHER Approved Type 2 Diabetes ClinicalTrials.gov
    Glucose Solution 2 OTHER Approved Type 2 Diabetes ClinicalTrials.gov
    Glucose Solution 1 OTHER Approved Type 2 Diabetes ClinicalTrials.gov
    RD133 DRUG Phase EARLY_PHASE1 Solid Tumor ClinicalTrials.gov
    LUCAR-20S CAR-T cells DRUG Phase PHASE1 Diffuse Large B Cell Lymphoma ClinicalTrials.gov
    CD19/CD20 Dual-CAR-T cells BIOLOGICAL Phase PHASE1 B-cell Leukemia ClinicalTrials.gov
    GC007F BIOLOGICAL Phase EARLY_PHASE1 B-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Dietary intervention: nuts and wholegrains with dietary advice for a blood-pressure lowering diet OTHER Approved Prehypertension ClinicalTrials.gov
    Bacillus subtilis BIOLOGICAL Approved COVID-19 Pneumonia ClinicalTrials.gov
    Human CD19Targeted T Cells Injection DRUG Phase PHASE2 B-cell Non-Hodgkin's Lymphoma ClinicalTrials.gov
    Home-use Test and Follow-up Questionnaire OTHER Preclinical Covid19 ClinicalTrials.gov
    ET019003-T Cells DRUG Phase PHASE1 Leukemia ClinicalTrials.gov
    CT103A DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    SARS-CoV-2 mRNA Vaccine BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    VIR-2482 DRUG Phase PHASE1 Influenza A ClinicalTrials.gov
    Live Attenuated Influenza Vaccine(freeze-dried) BIOLOGICAL Phase PHASE2 Influenza Prevention ClinicalTrials.gov
    Live Attenuated Influenza Vaccine(non freeze-dried) BIOLOGICAL Phase PHASE2 Influenza Prevention ClinicalTrials.gov
    Efficacy of LCAR-T2C CAR-T cells DRUG Phase PHASE1 CD4+ T Lymphocyte Tumor (T Cell Lymphoma and T Cell Leukemia) ClinicalTrials.gov
    collection of peripheral blood mononuclear cells from healthy volunteers PROCEDURE Approved Collection of Peripheral Blood Mononuclear Cells by Means of Apheresis ClinicalTrials.gov
    Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A) DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    GPC3-CAR-T cells BIOLOGICAL Phase PHASE1 Hepatocellular Carcinoma ClinicalTrials.gov
    CD19-STAR-T cells BIOLOGICAL Phase PHASE1 B Cell Malignancy ClinicalTrials.gov
    Adoptive TIL-TCM transfer therapy DRUG Phase EARLY_PHASE1 Advanced Pancreatic Cancer ClinicalTrials.gov
    CYNK-001 BIOLOGICAL Phase PHASE1 Coronavirus ClinicalTrials.gov
    live attenuated zoster vaccine BIOLOGICAL Phase PHASE3 Herpes Zoster ClinicalTrials.gov
    CD19/CD22-Dual-STAR-T BIOLOGICAL Phase PHASE1 Refractory and Relapsed B Cell Acute Leukemia ClinicalTrials.gov
    Avastin DRUG Phase PHASE1 Metastatic Colorectal Cancer ClinicalTrials.gov
    LY01008 DRUG Phase PHASE1 Metastatic Colorectal Cancer ClinicalTrials.gov
    CRTE7A2-01 TCR-T Cell BIOLOGICAL Phase PHASE1 Cervical Cancer ClinicalTrials.gov
    Interleukin-2 DRUG Phase PHASE1 Cervical Cancer ClinicalTrials.gov
    Fludarabine + Cyclophosphamide DRUG Phase PHASE1 Cervical Cancer ClinicalTrials.gov
    Dihydroartemisinin-Piperaquine drug combination DRUG Phase PHASE4 Malaria ClinicalTrials.gov
    Ad libitum energy intake BEHAVIORAL Preclinical Adults ClinicalTrials.gov
    EBV-TCR-T cells BIOLOGICAL Phase PHASE1 EBV Emia and EBV Positive PTLD After Allogenic HSCT ClinicalTrials.gov
    Recombinant L-IFN adenovirus injection DRUG Phase EARLY_PHASE1 Head and Neck Cancer ClinicalTrials.gov
    Selinexor DRUG Phase PHASE1 Extramedullary Multiple Myeloma ClinicalTrials.gov
    Human CD19-CD22 Targeted T Cells Injection DRUG Phase PHASE1 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    GILUPI CellCollector® DEVICE Approved Locally Advanced Breast Cancer ClinicalTrials.gov
    Camrelizumab plus Placebo BIOLOGICAL Phase PHASE2 Recurrent Glioblastoma ClinicalTrials.gov
    Camrelizumab plus GSC-DCV BIOLOGICAL Phase PHASE2 Recurrent Glioblastoma ClinicalTrials.gov
    Placebo (sodium chloride bufus, solvent for the preparation of dosage forms for injection 0.9%) OTHER Phase PHASE1 Covid19 ClinicalTrials.gov
    A single-center and single-arm design was used to evaluate the safety and preliminary immunogenicity of the adsorbed cell-free leukiche (three-component) combination vaccine BIOLOGICAL Phase PHASE1 Safety、Immunogenicity ClinicalTrials.gov
    JS019 BIOLOGICAL Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Standard Hysteroscopy Drape DEVICE Approved Hysteroscopic Surgery ClinicalTrials.gov
    Total Capture Drape DEVICE Approved Hysteroscopic Surgery ClinicalTrials.gov
    Herceptin DRUG Phase PHASE1 Breast Cancer Metastatic ClinicalTrials.gov
    Faceptor DRUG Phase PHASE1 Breast Cancer Metastatic ClinicalTrials.gov
    Pemetrexed DRUG Phase PHASE3 Non-small Cell Lung Carcinoma ClinicalTrials.gov
    Almonertinib DRUG Phase PHASE3 Non-small Cell Lung Carcinoma ClinicalTrials.gov
    HSA DRUG Phase PHASE2 Cirrhotic Ascites ClinicalTrials.gov
    OrsHSA DRUG Phase PHASE2 Cirrhotic Ascites ClinicalTrials.gov
    CD19-CAR-T cells BIOLOGICAL Phase PHASE1 B-cell Malignancy ClinicalTrials.gov
    Doxorubicin DRUG Phase PHASE1 Recurrent Ovarian Carcinoma ClinicalTrials.gov
    6B11-OCIK Injection DRUG Phase PHASE1 Recurrent Ovarian Carcinoma ClinicalTrials.gov
    Dietary and physical activity counselling BEHAVIORAL Approved Overweight and Obesity ClinicalTrials.gov
    TSB-9-W1 DRUG Phase PHASE1 Metastatic Colorectal Cancer ClinicalTrials.gov
    Fully Human Anti-CD19/CD22 Dual Target Chimeric Antigen Receptor Autologous T Cell Injection DRUG Phase PHASE1 B-cell Non-Hodgkin's Lymphoma ClinicalTrials.gov
    Placebo (sodium chloride, a 0.9% solution for the preparation of dosage forms for injections) OTHER Phase PHASE3 COVID-19 ClinicalTrials.gov
    fluoxetine hydrochloride capsule DRUG Approved Depression ClinicalTrials.gov
    Dental pulp mesenchymal cell vehicle DRUG Approved Depression ClinicalTrials.gov
    Dental pulp mesenchymal cell injection DRUG Approved Depression ClinicalTrials.gov
    Alemtuzumab BIOLOGICAL Phase PHASE2 B-cell Chronic Lymphocytic Leukemia ClinicalTrials.gov
    Multigene panel for next-generation sequencing DEVICE Preclinical Pancreatic Cancer Resectable ClinicalTrials.gov
    Vortioxetine Hemihydrobromide Orally Disintegrating Tablets DRUG Phase PHASE1 Major Depressive Disorder (MDD) ClinicalTrials.gov
    CT101a DRUG Phase PHASE1 AML ClinicalTrials.gov
    Recombinant novel coronavirus vaccine (Adenovirus type 5 vector) BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    Asian Noodles OTHER Approved Diabetes ClinicalTrials.gov
    Jasmine Rice OTHER Approved Diabetes ClinicalTrials.gov
    Wholegrain Spaghetti OTHER Approved Diabetes ClinicalTrials.gov
    Semolina Spaghetti OTHER Approved Diabetes ClinicalTrials.gov
    Wholegrain Penne OTHER Approved Diabetes ClinicalTrials.gov
    Semolina Penne OTHER Approved Diabetes ClinicalTrials.gov
    Targeted B7-H3 UCAR-T cell injection BIOLOGICAL Approved Advanced Glioma ClinicalTrials.gov
    Targeted IL-13 Rα2 UCAR-T cell injection BIOLOGICAL Approved Advanced Glioma ClinicalTrials.gov
    Comirnaty® BIOLOGICAL Phase PHASE1 SARS-CoV-2 Infection ClinicalTrials.gov
    ZR202a-CoV BIOLOGICAL Phase PHASE1 SARS-CoV-2 Infection ClinicalTrials.gov
    ZR202-CoV BIOLOGICAL Phase PHASE1 SARS-CoV-2 Infection ClinicalTrials.gov
    EndoTAG-1 DRUG Phase PHASE3 Metastatic Pancreas Cancer ClinicalTrials.gov
    HPV-16/18 placebo BIOLOGICAL Phase PHASE3 Human Papilloma Virus Infection Type 16 ClinicalTrials.gov
    HPV-16/18 vaccine BIOLOGICAL Phase PHASE3 Human Papilloma Virus Infection Type 16 ClinicalTrials.gov
    RGV004 BIOLOGICAL Phase PHASE1 Relapsed or Refractory B-cell Lymphoma ClinicalTrials.gov
    NeoPep Vaccine2 plus Poly-ICLC DRUG Approved Glioma, Malignant ClinicalTrials.gov
    NeoPep Vaccine1 plus Poly-ICLC DRUG Approved Glioma, Malignant ClinicalTrials.gov
    Sodium chloride DRUG Phase PHASE1 COVID-19 Pandemic ClinicalTrials.gov
    Lyophilized COVID-19 mRNA Vaccine BIOLOGICAL Phase PHASE1 COVID-19 Pandemic ClinicalTrials.gov
    SR-T100 gel with 2.3% of SM DRUG Phase PHASE2 Common Wart ClinicalTrials.gov
    SR-T100 gel with 1.0% of SM DRUG Phase PHASE2 Common Wart ClinicalTrials.gov
    Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha) BIOLOGICAL Phase PHASE3 Cervical Cancer ClinicalTrials.gov
    KD6001 Injection BIOLOGICAL Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Laboratory biomarker analysis OTHER Preclinical Hepatocellular Carcinoma ClinicalTrials.gov
    Liquid biopsy analysis OTHER Preclinical Hepatocellular Carcinoma ClinicalTrials.gov
    Methylation and epigenetic analysis OTHER Preclinical Hepatocellular Carcinoma ClinicalTrials.gov
    Metabolomics profiling OTHER Preclinical Hepatocellular Carcinoma ClinicalTrials.gov
    Immunohistochemistry OTHER Preclinical Hepatocellular Carcinoma ClinicalTrials.gov
    Mass spectrometry OTHER Preclinical Hepatocellular Carcinoma ClinicalTrials.gov
    Polymerase chain reaction OTHER Preclinical Hepatocellular Carcinoma ClinicalTrials.gov
    Proteomic profiling OTHER Preclinical Hepatocellular Carcinoma ClinicalTrials.gov
    Protein expression analysis OTHER Preclinical Hepatocellular Carcinoma ClinicalTrials.gov
    Genomic analysis OTHER Preclinical Hepatocellular Carcinoma ClinicalTrials.gov
    Gene expression analysis OTHER Preclinical Hepatocellular Carcinoma ClinicalTrials.gov
    202-CoV standard dose BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    202-CoV low antigen dose BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    202-CoV low adjuvant dose BIOLOGICAL Phase PHASE2 COVID-19 ClinicalTrials.gov
    ApoGraft DRUG Phase PHASE1 Acute Graft Versus Host Disease ClinicalTrials.gov
    A Lyophilized COVID-19 mRNA Vaccine BIOLOGICAL Phase PHASE1 COVID-19 Pandemic ClinicalTrials.gov
    Sintilimab DRUG Phase PHASE3 Esophageal Squamous Cell Carcinoma ClinicalTrials.gov
    Gemcitabine Hydrochloride DRUG Phase PHASE3 Triple-Negative Breast Cancer ClinicalTrials.gov
    Autologous FMT OTHER Approved Parkinson Disease ClinicalTrials.gov
    Donor FMT OTHER Approved Parkinson Disease ClinicalTrials.gov
    Sargramostim DRUG Phase PHASE4 COVID-19 ClinicalTrials.gov
    Placebo (Sodium chloride bufus, 0.9%) OTHER Phase PHASE2 Smallpox ClinicalTrials.gov
    Live Smallpox Vaccine BIOLOGICAL Phase PHASE2 Smallpox ClinicalTrials.gov
    VAC∆6 vaccine (10⁶ PFU) BIOLOGICAL Phase PHASE2 Smallpox ClinicalTrials.gov
    VAC∆6 vaccine (10⁷ PFU) BIOLOGICAL Phase PHASE2 Smallpox ClinicalTrials.gov
    No prospective interventions OTHER Phase PHASE4 Japanese Encephalitis ClinicalTrials.gov
    Japanese Encephalitis Vaccine (Vero Cell), Inactivated; BIOLOGICAL Phase PHASE4 Japanese Encephalitis ClinicalTrials.gov
    Toripalimab DRUG Phase PHASE1 Melanoma ClinicalTrials.gov
    KD6001 DRUG Phase PHASE1 Melanoma ClinicalTrials.gov
    Reading Newspaper BEHAVIORAL Approved Alcohol Use Disorder ClinicalTrials.gov
    Barlab-Exposure BEHAVIORAL Approved Alcohol Use Disorder ClinicalTrials.gov
    Ergometer BEHAVIORAL Approved Alcohol Use Disorder ClinicalTrials.gov
    Trier Social Stress Test BEHAVIORAL Approved Alcohol Use Disorder ClinicalTrials.gov
    Ad5-nCoV BIOLOGICAL Phase PHASE1 COVID-19 ClinicalTrials.gov
    CD19-targeted Chimeric Antigen Receptor (CAR) T Cells BIOLOGICAL Phase PHASE1 Acute Lymphocytic Leukemia ClinicalTrials.gov
    carbimazole (CMZ) or thiamazole (TMZ) DRUG Preclinical Hyperthyroidism ClinicalTrials.gov
    Low dose almond paste and inulin OTHER Approved Cardiovascular Diseases ClinicalTrials.gov
    Almond paste and inulin OTHER Approved Cardiovascular Diseases ClinicalTrials.gov
    Almond paste OTHER Approved Cardiovascular Diseases ClinicalTrials.gov
    Bread control OTHER Approved Cardiovascular Diseases ClinicalTrials.gov
    Glucose control OTHER Approved Cardiovascular Diseases ClinicalTrials.gov
    Lyophilized rabies vaccine for human use (Vero cells) BIOLOGICAL Phase EARLY_PHASE1 Rabies Virus Infection ClinicalTrials.gov
    Natural full human monoclonal antibody CBB 1 injection placebo DRUG Phase EARLY_PHASE1 Rabies Virus Infection ClinicalTrials.gov
    Rabies Human Immunoglobulin (HRIG) DRUG Phase EARLY_PHASE1 Rabies Virus Infection ClinicalTrials.gov
    Natural full human monoclonal antibody CBB 1 injection DRUG Phase EARLY_PHASE1 Rabies Virus Infection ClinicalTrials.gov
    Observational Survey OTHER Preclinical Nutrition, Healthy ClinicalTrials.gov
    BCMA CAR-T cells injection DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Neulasta DRUG Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Vegan burger BEHAVIORAL Approved Cardiometabolic Health ClinicalTrials.gov
    Conventional burger BEHAVIORAL Approved Cardiometabolic Health ClinicalTrials.gov
    Matched vehicle DRUG Phase PHASE2 Alzheimer's Disease or Vascular Dementia ClinicalTrials.gov
    BAC treatment DRUG Phase PHASE2 Alzheimer's Disease or Vascular Dementia ClinicalTrials.gov
    Relma-cel BIOLOGICAL Phase PHASE1 Systemic Lupus Erythematosus ClinicalTrials.gov
    VIR-7831 (sotrovimab) BIOLOGICAL Phase PHASE2 Covid19 ClinicalTrials.gov
    Low sugar variant 5 OTHER Approved Pre Diabetes ClinicalTrials.gov
    Low sugar variant 4 OTHER Approved Pre Diabetes ClinicalTrials.gov
    Low sugar variant 3 OTHER Approved Pre Diabetes ClinicalTrials.gov
    Low sugar variant 2 OTHER Approved Pre Diabetes ClinicalTrials.gov
    Low sugar variant 1 OTHER Approved Pre Diabetes ClinicalTrials.gov
    Standard Crokao OTHER Approved Pre Diabetes ClinicalTrials.gov
    Control 2 OTHER Approved Pre Diabetes ClinicalTrials.gov
    Control 1 OTHER Approved Pre Diabetes ClinicalTrials.gov
    Ganciclovir DRUG Phase PHASE4 Cytomegalovirus Infections ClinicalTrials.gov
    Foscarnet DRUG Phase PHASE4 Cytomegalovirus Infections ClinicalTrials.gov
    donor derived cytomegalovirus specific T lymphocytes BIOLOGICAL Phase PHASE4 Cytomegalovirus Infections ClinicalTrials.gov
    CMV-TCR-T cells BIOLOGICAL Phase PHASE1 CMV Infection or Reactivation After Allogenic HSCT ClinicalTrials.gov
    Sotrovimab BIOLOGICAL Preclinical Covid19 ClinicalTrials.gov
    Sham Injection DEVICE Phase PHASE2 Leber's Hereditary Optic Neuropathy (LHON) ClinicalTrials.gov
    NR082 injection DRUG Phase PHASE2 Leber's Hereditary Optic Neuropathy (LHON) ClinicalTrials.gov
    Vortioxetine Hydrobromide Tablets DRUG Phase PHASE1 Major Depressive Disorder (MDD) ClinicalTrials.gov
    Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) For Inhalation BIOLOGICAL Approved COVID-19 ClinicalTrials.gov
    Bivalent COVID-19 mRNA Vaccine BIOLOGICAL Approved COVID-19 ClinicalTrials.gov
    Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For Inhalation BIOLOGICAL Approved COVID-19 ClinicalTrials.gov
    Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris) BIOLOGICAL Phase PHASE3 HPV Infection ClinicalTrials.gov
    Human BCMA targeted CAR-NK cells injection DRUG Phase EARLY_PHASE1 Multiple Myeloma ClinicalTrials.gov
    Human CD19 Targeted DASH CAR-T Cells Injection DRUG Phase EARLY_PHASE1 B-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    human amniotic epithelial cells (hAECs) transplantation BIOLOGICAL Phase PHASE1 Primary Ovarian Insufficiency ClinicalTrials.gov
    CAL056 mesylate DRUG Phase PHASE1 Resistant or Refractory Solid Tumors ClinicalTrials.gov
    Diet BEHAVIORAL Approved Obesity ClinicalTrials.gov
    Physical Trainings BEHAVIORAL Approved Obesity ClinicalTrials.gov
    VIR-1111 BIOLOGICAL Phase PHASE1 HIV I Infection ClinicalTrials.gov
    Capecitabine tablets DRUG Phase PHASE3 Colorectal Cancer ClinicalTrials.gov
    Human Amniotic Epithelial Stem Cells BIOLOGICAL Phase EARLY_PHASE1 Parkinson's Disease ClinicalTrials.gov
    NIOCH-14, 200 mg capsule: 3 capsules (200 mg each) of NIOCH-14 twice a day orally for 6 days. (Total 1200 mg NIOCH-14 per day for 6 days) DRUG Phase PHASE1 Smallpox ClinicalTrials.gov
    NIOCH-14, 200 mg capsule: 3 capsules (200 mg each) of NIOCH-14 a day orally for 6 days. (Total 600 mg NIOCH-14 per day for 6 days) DRUG Phase PHASE1 Smallpox ClinicalTrials.gov
    NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 a day orally for 6 days DRUG Phase PHASE1 Smallpox ClinicalTrials.gov
    NIOCH-14, 200 mg capsule: 6 capsules (200 mg each) of NIOCH-14 per day orally. (Total 1200 mg NIOCH-14 per day) DRUG Phase PHASE1 Smallpox ClinicalTrials.gov
    NIOCH-14, 200 mg capsule: 3 capsules (200 mg each) of NIOCH-14 once orally. (Total 600 mg NIOCH-14 per day) DRUG Phase PHASE1 Smallpox ClinicalTrials.gov
    NIOCH-14, 200 mg capsule: 1 capsule (200 mg) of NIOCH-14 once orally DRUG Phase PHASE1 Smallpox ClinicalTrials.gov
    The study being observational in nature, there is no intervention. The investigators will only collect cervical samples from married women within a specified age range at different intervals. BIOLOGICAL Preclinical Cervical Cancer ClinicalTrials.gov
    Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 20mg DRUG Phase PHASE1 Major Depressive Disorder (MDD ClinicalTrials.gov
    Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 10mg DRUG Phase PHASE1 Major Depressive Disorder (MDD ClinicalTrials.gov
    Vortioxetine Hemihydrobromide Orally Disintegrating Tablets 5mg DRUG Phase PHASE1 Major Depressive Disorder (MDD ClinicalTrials.gov
    CAR-NK-CD19 Cells BIOLOGICAL Phase PHASE1 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Prodencel; an autologous dendritic cell therapeutic tumor vaccine BIOLOGICAL Phase PHASE1 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov
    Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops DRUG Phase PHASE1 Dry Eye Disease ClinicalTrials.gov
    ZR-202-CoV BIOLOGICAL Phase PHASE1 COVID-19 ClinicalTrials.gov
    Sugar 2 OTHER Approved Diabete Type 2 ClinicalTrials.gov
    Sugar 1 OTHER Approved Diabete Type 2 ClinicalTrials.gov
    Starch 4 OTHER Approved Diabete Type 2 ClinicalTrials.gov
    Starch 3 OTHER Approved Diabete Type 2 ClinicalTrials.gov
    Starch 2 OTHER Approved Diabete Type 2 ClinicalTrials.gov
    Starch 1 OTHER Approved Diabete Type 2 ClinicalTrials.gov
    placebo (saline) BIOLOGICAL Phase EARLY_PHASE1 Parkinson's Disease ClinicalTrials.gov
    hAESCs treatment BIOLOGICAL Phase EARLY_PHASE1 Parkinson's Disease ClinicalTrials.gov
    Rest (60 minutes) OTHER Preclinical Vitamin D ClinicalTrials.gov
    Treadmill-Based Exercise (60% VO2 Max for 60 minutes) OTHER Preclinical Vitamin D ClinicalTrials.gov
    IMC002 injection BIOLOGICAL Phase PHASE1 Advanced Digestive System Tumor ClinicalTrials.gov
    PMR Tablet 135 mg DRUG Phase PHASE1 Intermittent Claudication ClinicalTrials.gov
    Cilostazol Tablet 100 mg DRUG Phase PHASE1 Intermittent Claudication ClinicalTrials.gov
    IMS001 BIOLOGICAL Phase PHASE1 Multiple Sclerosis ClinicalTrials.gov
    Sotrovimab (Gen2) BIOLOGICAL Phase PHASE2 Covid19 ClinicalTrials.gov
    Sotrovimab (Gen1) BIOLOGICAL Phase PHASE2 Covid19 ClinicalTrials.gov
    Live smallpox vaccine (Smallpox vaccine) + The OspaVir® inactivated smallpox vaccine BIOLOGICAL Phase PHASE1 Smallpox ClinicalTrials.gov
    VAC∆6 vaccine - twice at a dose of 10⁶ PFU BIOLOGICAL Phase PHASE1 Smallpox ClinicalTrials.gov
    VAC∆6 vaccine - once at a dose of 10⁷ PFU BIOLOGICAL Phase PHASE1 Smallpox ClinicalTrials.gov
    VAC∆6 vaccine - оnce at a dose of 10⁶ PFU BIOLOGICAL Phase PHASE1 Smallpox ClinicalTrials.gov
    Interferon Alfa-2a DRUG Phase PHASE2 Hepatitis C, Chronic ClinicalTrials.gov
    Ribavirin DRUG Phase PHASE2 Hepatitis C, Chronic ClinicalTrials.gov
    High Dose Recombinant Herpes Zoster Vaccine (LZ901) BIOLOGICAL Phase PHASE1 Herpes Zoster ClinicalTrials.gov
    Low Dose Recombinant Herpes Zoster Vaccine (LZ901) BIOLOGICAL Phase PHASE1 Herpes Zoster ClinicalTrials.gov
    Sanofi Pasteur Menactra® vaccine BIOLOGICAL Phase PHASE4 Neisseria Meningitides Meningitis ClinicalTrials.gov
    Yuxi Walvax MPV ACYW® vaccine BIOLOGICAL Phase PHASE4 Neisseria Meningitides Meningitis ClinicalTrials.gov
    GARDASIL ®9 BIOLOGICAL Phase PHASE3 Cervical Cancer ClinicalTrials.gov
    Zerun HPV-9 BIOLOGICAL Phase PHASE3 Cervical Cancer ClinicalTrials.gov
    18F-PSMA-1007 DRUG Preclinical Prostate Cancer ClinicalTrials.gov
    Placebo capsule OTHER Approved Phenylketonuria ClinicalTrials.gov
    CBT102-A capsule BIOLOGICAL Approved Phenylketonuria ClinicalTrials.gov
    whole genomic methylation and fragmentation profile analysis of cfDNA GENETIC Preclinical Gastric Cancer ClinicalTrials.gov
    OsrhAAT 60 mg/kg IV DRUG Phase PHASE1 Emphysema Secondary to Congenital AATD ClinicalTrials.gov
    OsrhAAT 40 mg/kg IV DRUG Phase PHASE1 Emphysema Secondary to Congenital AATD ClinicalTrials.gov
    OsrhAAT 20 mg/kg IV DRUG Phase PHASE1 Emphysema Secondary to Congenital AATD ClinicalTrials.gov
    OsrhAAT 10 mg/kg IV DRUG Phase PHASE1 Emphysema Secondary to Congenital AATD ClinicalTrials.gov
    OsrhAAT 3 mg/kg IV DRUG Phase PHASE1 Emphysema Secondary to Congenital AATD ClinicalTrials.gov
    OsrhAAT 1 mg/kg IV DRUG Phase PHASE1 Emphysema Secondary to Congenital AATD ClinicalTrials.gov
    STT-5058 DRUG Phase PHASE1 Hypertriglyceridemia ClinicalTrials.gov
    XEN DEVICE Approved Glaucoma ClinicalTrials.gov
    GELA DEVICE Approved Glaucoma ClinicalTrials.gov
    GST-HG171 Tablets DRUG Approved COVID-19 Pneumonia ClinicalTrials.gov
    Treatment OTHER Approved Nutrition, Healthy ClinicalTrials.gov
    TCR-MAGE-A4 T-Cells DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    YTS109 OTHER Approved Systemic Lupus Erythematosus ClinicalTrials.gov
    KD6005 DRUG Phase PHASE1 Rheumatoid Arthritis ClinicalTrials.gov
    Intervention (Chlorella microalgae (Chlorella vulgaris) protein isolates) OTHER Approved Nutrition, Healthy ClinicalTrials.gov
    Intervention (Chlorella microalgae (Chlorella vulgaris) whole biomass) OTHER Approved Nutrition, Healthy ClinicalTrials.gov
    Intervention (Laver/nori macroalgae (Porphyra umbillicus) protein isolates) OTHER Approved Nutrition, Healthy ClinicalTrials.gov
    Intervention (Laver/nori (Porphyra umbillicus) macroalgae whole biomass) OTHER Approved Nutrition, Healthy ClinicalTrials.gov
    Soy control OTHER Approved Nutrition, Healthy ClinicalTrials.gov
    placebo of GST-HG171 DRUG Phase PHASE1 COVID-19 ClinicalTrials.gov
    GST-HG171 DRUG Phase PHASE1 COVID-19 ClinicalTrials.gov
    GST-HG121 tablets DRUG Phase PHASE1 Pharmacokinetics ClinicalTrials.gov
    BA1202 DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Placebo for Recombinant Human Chymotrypsin(OsrhCT) DRUG Phase PHASE1 Pleurisy ClinicalTrials.gov
    Recombinant Human Chymotrypsin(OsrhCT) DRUG Phase PHASE1 Pleurisy ClinicalTrials.gov
    Dalpiciclib combined with aromatase inhibitors DRUG Phase PHASE2 Luminal B/HER2-negative Breast Cancer ClinicalTrials.gov
    Adsorbed tetanus vaccine (TT) BIOLOGICAL Phase EARLY_PHASE1 Clostridium Tetanus ClinicalTrials.gov
    Whole-human anti-tetanus toxin monoclonal antibody A82 / B86 injection placebo DRUG Phase EARLY_PHASE1 Clostridium Tetanus ClinicalTrials.gov
    Tetanus human immunoglobulin (HTIG) DRUG Phase EARLY_PHASE1 Clostridium Tetanus ClinicalTrials.gov
    Human anti-tetanus toxin monoclonal antibody A82 / B86 injection combination preparation DRUG Phase EARLY_PHASE1 Clostridium Tetanus ClinicalTrials.gov
    Single dose of 75 grams glucose in 200ml water OTHER Approved PreDiabetes ClinicalTrials.gov
    BRII-179 (VBI-2601) BIOLOGICAL Phase PHASE2 Hepatitis B, Chronic ClinicalTrials.gov
    BRII-179 (VBI-2601) with IFN-α BIOLOGICAL Phase PHASE2 Hepatitis B, Chronic ClinicalTrials.gov
    BRII-835 (VIR-2218) DRUG Phase PHASE2 Hepatitis B, Chronic ClinicalTrials.gov
    177Lu-LNC1003 Injection group 3 DRUG Phase PHASE1 Metastatic Castration-resistant Prostate Cancer, mCRPC ClinicalTrials.gov
    177Lu-LNC1003 Injection group 2 DRUG Phase PHASE1 Metastatic Castration-resistant Prostate Cancer, mCRPC ClinicalTrials.gov
    177Lu-LNC1003 Injection group 1 DRUG Phase PHASE1 Metastatic Castration-resistant Prostate Cancer, mCRPC ClinicalTrials.gov
    RC19D2 cell injection BIOLOGICAL Phase PHASE1 Recurrent Diffuse Large B-Cell Lymphoma ClinicalTrials.gov
    SK10 DRUG Phase PHASE1 Chemotherapy-induced Diarrhea ClinicalTrials.gov
    anti-CD7 CAR-T BIOLOGICAL Phase PHASE1 CD7+ Acute Leukemia ClinicalTrials.gov
    Investigational meal 4- Formulated plant-based protein foods [Gyoza (11 pieces) and Luncheon meat (5 pieces)] OTHER Approved Nutrition, Healthy ClinicalTrials.gov
    Investigational meal 3- Formulated plant-based protein foods [Siew mai (6 pieces) and Ngoh hiang (1 piece cut into 2)] OTHER Approved Nutrition, Healthy ClinicalTrials.gov
    Investigational meal 2- Commercial animal-based protein foods [Gyoza (11 pieces) and Luncheon meat (5 pieces)] OTHER Approved Nutrition, Healthy ClinicalTrials.gov
    Investigational meal 1 - Commercial animal-based protein foods [Siew mai (6 pieces) and Ngoh hiang (2 pieces)] OTHER Approved Nutrition, Healthy ClinicalTrials.gov
    RG002 injection BIOLOGICAL Phase PHASE1 Human Papillomavirus Associated Intraepithelial Neoplasia ClinicalTrials.gov
    Tumor Vaccine BIOLOGICAL Phase PHASE1 Lung Cancer ClinicalTrials.gov
    Liquid Support Treatment OTHER Approved COVID-19 Pneumonia ClinicalTrials.gov
    Signal Therapy provided by Dr.Biolyse device DEVICE Approved COVID-19 Pneumonia ClinicalTrials.gov
    Natural full human monoclonal antibody CBB 1 injection 100.0µg/kg DRUG Phase PHASE2 Rabies Virus Infection ClinicalTrials.gov
    Natural full human monoclonal antibody CBB 1 injection 50.0µg/kg DRUG Phase PHASE2 Rabies Virus Infection ClinicalTrials.gov
    Placebo among 9-17 yrs BIOLOGICAL Phase PHASE1 Penile Cancer ClinicalTrials.gov
    Placebo among 18-45 yrs BIOLOGICAL Phase PHASE1 Penile Cancer ClinicalTrials.gov
    ritonavir DRUG Phase PHASE1 COVID-19 Respiratory Infection ClinicalTrials.gov
    GST-HG171/ritonavir DRUG Phase PHASE1 COVID-19 Respiratory Infection ClinicalTrials.gov
    hUC-MSC_Prolonged DRUG Phase PHASE1 Acute-On-Chronic Liver Failure ClinicalTrials.gov
    hUC-MSC DRUG Phase PHASE1 Acute-On-Chronic Liver Failure ClinicalTrials.gov
    standard medical treatment DRUG Phase PHASE1 Acute-On-Chronic Liver Failure ClinicalTrials.gov
    Gemcitabine+Abraxane DRUG Phase EARLY_PHASE1 Pancreatic Cancer ClinicalTrials.gov
    SJ-Neo006 BIOLOGICAL Phase EARLY_PHASE1 Pancreatic Cancer ClinicalTrials.gov
    Camrelizumab DRUG Phase EARLY_PHASE1 Pancreatic Cancer ClinicalTrials.gov
    Surgery PROCEDURE Phase EARLY_PHASE1 Pancreatic Cancer ClinicalTrials.gov
    CD19&CD20 bispecific CAR-T cells DRUG Phase PHASE1 B-Cell Lymphoblastic Leukemia/Lymphoma ClinicalTrials.gov
    Claudin 18.2 CAR-T BIOLOGICAL Phase PHASE1 Gastric Cancer ClinicalTrials.gov
    CD19-targeted Chimeric Antigen Receptor(CAR) T Cells BIOLOGICAL Phase PHASE2 Lymphoma, Non-Hodgkin ClinicalTrials.gov
    GT201 DRUG Phase PHASE1 Solid Tumor, Adult ClinicalTrials.gov
    Food/meal intervention OTHER Approved Effects of; Food ClinicalTrials.gov
    DeepTag-GPRC5D Targeted CAR T-cells BIOLOGICAL Phase PHASE1 Relapse/Refractory Multiple Myeloma ClinicalTrials.gov
    Pfizer PCV13 BIOLOGICAL Phase PHASE3 Pneumococcal Disease, Invasive ClinicalTrials.gov
    Walvax PCV13-TT BIOLOGICAL Phase PHASE3 Pneumococcal Disease, Invasive ClinicalTrials.gov
    Relmacabtagene Autoleucel BIOLOGICAL Preclinical Large B-cell Lymphoma ClinicalTrials.gov
    CD19-BAFF Targeted CAR T-cells BIOLOGICAL Phase EARLY_PHASE1 Autoimmune Diseases ClinicalTrials.gov
    SNC-109 CAR-T Cells DRUG Phase PHASE1 Recurrent Glioblastoma Multiforme ClinicalTrials.gov
    Recombinant Herpes Zoster Vaccine Placebo BIOLOGICAL Phase PHASE3 Vaccine-Preventable Diseases ClinicalTrials.gov
    Recombinant Herpes Zoster Vaccine BIOLOGICAL Phase PHASE3 Vaccine-Preventable Diseases ClinicalTrials.gov
    SNC115 injection DRUG Phase PHASE1 Recurrent/Refractory Small Cell Lung Cancer Lung Large Cell Neuroendocrine Carcinoma ClinicalTrials.gov
    GARDASIL® BIOLOGICAL Phase PHASE3 Cervical Cancer ClinicalTrials.gov
    9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha) BIOLOGICAL Phase PHASE3 Cervical Cancer ClinicalTrials.gov
    Oral enterobacterium capsules placebo BIOLOGICAL Phase PHASE2 Liver Cancer ClinicalTrials.gov
    Lenvatinib + PD-1 monoclonal antibody DRUG Phase PHASE2 Liver Cancer ClinicalTrials.gov
    Oral enterobacterium capsules BIOLOGICAL Phase PHASE2 Liver Cancer ClinicalTrials.gov
    18F-FDG Injection DRUG Phase PHASE3 Non-Small Cell Lung Cancer NSCLC ClinicalTrials.gov
    18F-Alfatide Injection DRUG Phase PHASE3 Non-Small Cell Lung Cancer NSCLC ClinicalTrials.gov
    CART-BCMA DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    JWCAR201 BIOLOGICAL Phase PHASE1 B-cell Tumors ClinicalTrials.gov
    F-652 BIOLOGICAL Phase PHASE2 COVID-19 Pneumonia ClinicalTrials.gov
    Acriva BB UDM 611 DEVICE Approved Lens Implantation, Intraocular ClinicalTrials.gov
    DCBY02 DRUG Phase PHASE1 Advanced or Metastatic Solid Tumors ClinicalTrials.gov
    Bevacizumab DRUG Phase PHASE1 Advanced HCC ClinicalTrials.gov
    Tislelizumab DRUG Phase PHASE1 Advanced HCC ClinicalTrials.gov
    Human Amniotic Epithelial Stem Cell Injection DRUG Phase PHASE1 GVHD,Acute ClinicalTrials.gov
    Remdesivir BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    VIR-7831 BIOLOGICAL Phase PHASE3 COVID-19 ClinicalTrials.gov
    Regorafenib DRUG Preclinical Hepatocellular Carcinoma Non-resectable ClinicalTrials.gov
    Donafenib DRUG Preclinical Hepatocellular Carcinoma Non-resectable ClinicalTrials.gov
    Sorafenib DRUG Preclinical Hepatocellular Carcinoma Non-resectable ClinicalTrials.gov
    apatinib plus camrelizumab DRUG Preclinical Hepatocellular Carcinoma Non-resectable ClinicalTrials.gov
    Bevacizumab plus Atezolizumab DRUG Preclinical Hepatocellular Carcinoma Non-resectable ClinicalTrials.gov
    Bevacizumab Biosimilar IBI305 plus sintilimab DRUG Preclinical Hepatocellular Carcinoma Non-resectable ClinicalTrials.gov
    Anti-PD-1 monoclonal antibody DRUG Preclinical Hepatocellular Carcinoma Non-resectable ClinicalTrials.gov
    Lenvatinib DRUG Preclinical Hepatocellular Carcinoma Non-resectable ClinicalTrials.gov
    TACE PROCEDURE Preclinical Hepatocellular Carcinoma Non-resectable ClinicalTrials.gov
    EC regimen DRUG Phase PHASE1 Neutropenia ClinicalTrials.gov
    biopsy of tumor before treatment OTHER Preclinical Precise Prediction of Therapy Efficiency ClinicalTrials.gov
    Wheat flour control OTHER Approved Glycaemic Response ClinicalTrials.gov
    PulseOn OTHER Approved Glycaemic Response ClinicalTrials.gov
    placebo (cell preservation solution) BIOLOGICAL Phase EARLY_PHASE1 Acute Graft Versus Host Disease ClinicalTrials.gov
    Human amniotic epithelial stem cells（hAESCs） BIOLOGICAL Phase EARLY_PHASE1 Acute Graft Versus Host Disease ClinicalTrials.gov
    APRIL-BAFF-Bicephali CAR-T cells OTHER Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Cold Stimulus OTHER Approved Brown Adipose Tissue ClinicalTrials.gov
    Capsinoids OTHER Approved Brown Adipose Tissue ClinicalTrials.gov
    Nanobody-based biepitope BCMA-targeting CAR-T cells DRUG Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    Cryotherapy Treatment PROCEDURE Approved Chronic Cough ClinicalTrials.gov
    General treatment PROCEDURE Approved Chronic Cough ClinicalTrials.gov
    Neoadjuvant Radiotherapy RADIATION Phase PHASE2 Locally Advanced Rectal Cancer ClinicalTrials.gov
    Capecitabine DRUG Phase PHASE2 Locally Advanced Rectal Cancer ClinicalTrials.gov
    AK104 DRUG Phase PHASE2 Locally Advanced Rectal Cancer ClinicalTrials.gov
    IASO-782 injection DRUG Phase PHASE1 Autoimmune Thrombocytopenia ClinicalTrials.gov
    CRTE7A2-01 TCR-T cell therapy DRUG Phase PHASE1 Cervical Cancer ClinicalTrials.gov
    Itraconazole DRUG Phase PHASE1 Healthy Participant ClinicalTrials.gov
    CAR-GPC3 T cells BIOLOGICAL Phase PHASE1 Liver Carcinoma ClinicalTrials.gov
    JWCAR029 (Relmacabtagene Autoleucel) GENETIC Phase PHASE1 Leukemia, Lymphocytic, Chronic, B-Cell ClinicalTrials.gov
    After preconditioning with Fludarabine and Cyclophosphamide, F01 will be evaluated. DRUG Phase PHASE1 Autoimmune Diseases ClinicalTrials.gov
    Plasbumin®-20 DRUG Phase PHASE3 Hypoalbuminemia ClinicalTrials.gov
    OsrHSA DRUG Phase PHASE3 Hypoalbuminemia ClinicalTrials.gov
    JWCAR029 (CD19-targeted Chimeric Antigen Receptor Cells) BIOLOGICAL Phase PHASE1 Diffuse Large B Cell Lymphoma ClinicalTrials.gov
    Allogeneic NK（CCT-ANK-11) DRUG Phase EARLY_PHASE1 Solid Tumors (Pancreatic Cancer, Esophageal Cancer, Gastric Cancer, Cholangiocarcinoma, Lung Cancer and Ovarian Cancer) ClinicalTrials.gov
    Temporary cessation of all oral hygiene BEHAVIORAL Preclinical Gingivitis ClinicalTrials.gov
    SR419 DRUG Phase PHASE2 Postherpetic Neuralgia ClinicalTrials.gov
    After preconditioning with chemotherapy, F01 will be evaluated. BIOLOGICAL Phase PHASE1 Lupus Erythematosis ClinicalTrials.gov
    XNW5004 tablets DRUG Phase PHASE1 Advanced Tumor ClinicalTrials.gov
    PMR Tablet 145 mg DRUG Phase PHASE1 Intermittent Claudication ClinicalTrials.gov
    PCV13 BIOLOGICAL Phase PHASE4 Pneumonia ClinicalTrials.gov
    Placebo to Biologic OTHER Phase PHASE1 Covid19 ClinicalTrials.gov
    Islet organoids transplantation OTHER Approved T3c Diabetes ClinicalTrials.gov
    CRC+HIPEC PROCEDURE Preclinical Peritoneal Metastases ClinicalTrials.gov
    DF-003 DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Autologous tumor infiltrating lymphocyte injection（GT201） BIOLOGICAL Phase EARLY_PHASE1 Adult Gynecological Tumors ClinicalTrials.gov
    BCMA CART DRUG Phase PHASE1 Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for ASCT. And Meet Any of the Following uhr-mm Definitions ClinicalTrials.gov
    CD19&CD22 bispecific CAR-T cells DRUG Phase PHASE1 B-Cell Lymphoblastic Leukemia/Lymphoma ClinicalTrials.gov
    IB-T101 injection BIOLOGICAL Phase PHASE1 Advanced Clear Renal Cell Carcinoma ClinicalTrials.gov
    CAR-T Cells infusion（CAR2219,CAR2019, CAR19 etc） DRUG Phase PHASE1 Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL) ClinicalTrials.gov
    BA1302 DRUG Phase PHASE1 Non-Small Cell Lung Cancer ClinicalTrials.gov
    wIPV+bOPV BIOLOGICAL Phase PHASE3 Poliomyelitis ClinicalTrials.gov
    sIPV+bOPV BIOLOGICAL Phase PHASE3 Poliomyelitis ClinicalTrials.gov
    Normal Saline BIOLOGICAL Phase PHASE1 Herpes Zoster ClinicalTrials.gov
    Recombinant Zoster Vaccine (CHO cell) (Adjuvant control) BIOLOGICAL Phase PHASE1 Herpes Zoster ClinicalTrials.gov
    Zoster Vaccine, Live BIOLOGICAL Phase PHASE1 Herpes Zoster ClinicalTrials.gov
    Recombinant zoster vaccine(CHO cell)(low adjuvant) BIOLOGICAL Phase PHASE1 Herpes Zoster ClinicalTrials.gov
    15-valent recombinant human papillomavirus vaccine (Hansenulapolymorpha) BIOLOGICAL Phase PHASE1 HPV Infection ClinicalTrials.gov
    18F-LNC1007 Injection DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    SARS CoV-2 swabs PROCEDURE Preclinical COVID-19 ClinicalTrials.gov
    Bronchoalveolar lavage PROCEDURE Preclinical COVID-19 ClinicalTrials.gov
    BA1301 DRUG Phase PHASE1 Advanced Solid Tumours ClinicalTrials.gov
    BRII-835 DRUG Phase PHASE2 Chronic Hepatitis B Virus Infection ClinicalTrials.gov
    Antimicrobial Peptide PL-5 Topical Spray and Placebo DRUG Phase PHASE2 Diabetic Foot Ulcers ClinicalTrials.gov
    Test Group BIOLOGICAL Phase PHASE3 Prevention of Influenza ClinicalTrials.gov
    CD7 CAR-T combined with autologous hematopoietic stem cell transplantation DRUG Phase PHASE1 CD7+ Lymphoma ClinicalTrials.gov
    VRON-0200-AdC7 BIOLOGICAL Phase PHASE1 Chronic Hepatitis B ClinicalTrials.gov
    VRON-0200-AdC6 BIOLOGICAL Phase PHASE1 Chronic Hepatitis B ClinicalTrials.gov
    Diabetic foot ulcer treatment BIOLOGICAL Phase EARLY_PHASE1 Diabetic Foot Ulcer ClinicalTrials.gov
    68Ga-LNC1007 Injection DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Human Derived anti-CI135 CAR-T Injection DRUG Phase EARLY_PHASE1 Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    core decompression PROCEDURE Phase PHASE1 Osteonecrosis of Femoral Head ClinicalTrials.gov
    Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#) DRUG Phase PHASE1 Osteonecrosis of Femoral Head ClinicalTrials.gov
    Serplulimab Injection DRUG Phase PHASE1 Tumor Associated Lymph Node T Cell ClinicalTrials.gov
    Tumor Associated Lymph node T cell BIOLOGICAL Phase PHASE1 Tumor Associated Lymph Node T Cell ClinicalTrials.gov
    Stimus (NNG-DEPO) BIOLOGICAL Phase PHASE3 Anemia ClinicalTrials.gov
    Cold Stimulation and Browning Nutraceutical (CSBN) OTHER Approved Energy Expenditure ClinicalTrials.gov
    Browning Nutraceutical (BN) OTHER Approved Energy Expenditure ClinicalTrials.gov
    Cold Stimulation (CS) OTHER Approved Energy Expenditure ClinicalTrials.gov
    Opdivo® DRUG Phase PHASE3 Esophageal Squamous Cell Carcinoma ClinicalTrials.gov
    Fluorouracil DRUG Phase PHASE3 Esophageal Squamous Cell Carcinoma ClinicalTrials.gov
    LY01015 DRUG Phase PHASE3 Esophageal Squamous Cell Carcinoma ClinicalTrials.gov
    Air filtration system without filters (sham) DEVICE Approved Cancer Survivors ClinicalTrials.gov
    High efficiency particulate air filtration system (nightly and daily administration) DEVICE Approved Cancer Survivors ClinicalTrials.gov
    High efficiency particulate air filtration system (nightly administration) DEVICE Approved Cancer Survivors ClinicalTrials.gov
    Subcutaneous single and mutiple dose DRUG Phase PHASE1 Overweight or Obese ClinicalTrials.gov
    YY2201 DRUG Phase EARLY_PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    NaviFUS System DEVICE Approved Epilepsy, Temporal Lobe ClinicalTrials.gov
    A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patients With Advanced Solid Tumors BIOLOGICAL Phase PHASE1 Sarcoma ClinicalTrials.gov
    TPC: TMZ or Platinum (cisplatin or carboplatin)+VP-16 DRUG Phase PHASE2 Recurrent Glioblastoma ClinicalTrials.gov
    KH617 DRUG Phase PHASE2 Recurrent Glioblastoma ClinicalTrials.gov
    Standardized breakfast B OTHER Approved Glucose Metabolism Disorders ClinicalTrials.gov
    Standardized breakfast A OTHER Approved Glucose Metabolism Disorders ClinicalTrials.gov
    NGGT001 BIOLOGICAL Phase PHASE1 Bietti Crystalline Corneoretinal Dystrophy ClinicalTrials.gov
    Vebreltinib DRUG Phase PHASE1 Non-Small-Cell Lung Cancer ClinicalTrials.gov
    Immunotherapy Monitoring and Sample Collection BEHAVIORAL Preclinical Malignant Neoplasm ClinicalTrials.gov
    OB-002 DRUG Phase PHASE1 Metastatic Cancer ClinicalTrials.gov
    pneumococcal disease prevention BIOLOGICAL Phase PHASE3 Pneumococcal Vaccines ClinicalTrials.gov
    Dose level 4 group DRUG Phase PHASE1 Myasthenia Gravis, Generalized ClinicalTrials.gov
    Dose level 3 group DRUG Phase PHASE1 Myasthenia Gravis, Generalized ClinicalTrials.gov
    Dose level 2 group DRUG Phase PHASE1 Myasthenia Gravis, Generalized ClinicalTrials.gov
    Dose level 1 group DRUG Phase PHASE1 Myasthenia Gravis, Generalized ClinicalTrials.gov
    18-PSMA DRUG Phase PHASE1 Liver Metastasis Colon Cancer ClinicalTrials.gov
    KL003 Cell Injection Drug Product DRUG Phase PHASE1 Transfusion-dependent Beta-Thalassemia ClinicalTrials.gov
    Super1 TCR-T BIOLOGICAL Phase PHASE1 Sarcoma ClinicalTrials.gov
    GT101 BIOLOGICAL Phase EARLY_PHASE1 Adult ClinicalTrials.gov
    Dexamethasone DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Bortezomib DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Pomalidomide DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Daratumumab DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Equecabtagene Autoleucel Injection DRUG Phase PHASE3 Multiple Myeloma ClinicalTrials.gov
    Pemetrexed plus Carboplatin or Cisplatin DRUG Phase PHASE3 Non-Small-Cell Lung Cancer ClinicalTrials.gov
    Human Derived anti-BCMA CAR-T Injection DRUG Phase EARLY_PHASE1 Multiple Myeloma ClinicalTrials.gov
    conventional treatment DRUG Phase PHASE1 Heart Failure ClinicalTrials.gov
    HN2301 injection DRUG Approved Refractory Myasthenia Gravis ClinicalTrials.gov
    ANS03 DRUG Phase PHASE1 Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration ClinicalTrials.gov
    QY-1-T DRUG Approved Liver Cancer ClinicalTrials.gov
    Liaoning Chengda Inactivated Japanese Encephalitis Vaccine BIOLOGICAL Phase PHASE4 Japanese Encephalitis ClinicalTrials.gov
    YB1-X7 Injection (IV) DRUG Approved Advanced Solid Tumors ClinicalTrials.gov
    YB1-X7 Injection (IT) DRUG Approved Advanced Solid Tumors ClinicalTrials.gov
    Golimumab DRUG Phase PHASE3 Axial Spondyloarthritis ClinicalTrials.gov
    ABB DEVICE Approved Tooth Extraction ClinicalTrials.gov
    PRGF DEVICE Approved Tooth Extraction ClinicalTrials.gov
    CAR-GPRC5D DRUG Phase PHASE1 Relapsed/Refractory Multiple Myeloma ClinicalTrials.gov
    pegylated interferon-alfa 2a DRUG Phase PHASE2 Chronic Hepatitis B ClinicalTrials.gov
    Cannabidiol (CBD) Capsule 75mg DRUG Phase PHASE3 Insomnia ClinicalTrials.gov
    High dose Recombinant Trivalent Subunit Rotavirus Vaccine BIOLOGICAL Phase PHASE2 Rotavirus Infections ClinicalTrials.gov
    Mid dose Recombinant Trivalent Subunit Rotavirus Vaccine BIOLOGICAL Phase PHASE2 Rotavirus Infections ClinicalTrials.gov
    jzb30 DRUG Phase PHASE1 Bioequivalence ClinicalTrials.gov
    Gonal F DRUG Phase PHASE1 Bioequivalence ClinicalTrials.gov
    IL-2 DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Biospecimen Collection PROCEDURE Phase PHASE1 COVID-19 Infection ClinicalTrials.gov
    Questionnaire Administration OTHER Phase PHASE1 COVID-19 Infection ClinicalTrials.gov
    matching placebo DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    adjuvant chemotherapy regimens DRUG Approved Pancreatic Adenocarcinoma Resectable ClinicalTrials.gov
    Japanese Encephalitis Vaccine, Live BIOLOGICAL Phase PHASE4 Japanese Encephalitis Vaccine ClinicalTrials.gov
    Japanese Encephalitis Vaccine (Vero Cell), Inactivated BIOLOGICAL Phase PHASE4 Japanese Encephalitis Vaccine ClinicalTrials.gov
    5% GM-XANTHO [GM-XAN003] DRUG Phase PHASE2 Psoriasis ClinicalTrials.gov
    Canola oil only / 10 min preload OTHER Approved Postprandial Hyperglycemia ClinicalTrials.gov
    Spinach only / 10 min preload OTHER Approved Postprandial Hyperglycemia ClinicalTrials.gov
    20 min preload OTHER Approved Postprandial Hyperglycemia ClinicalTrials.gov
    15 min preload OTHER Approved Postprandial Hyperglycemia ClinicalTrials.gov
    10 min preload OTHER Approved Postprandial Hyperglycemia ClinicalTrials.gov
    5 min preload OTHER Approved Postprandial Hyperglycemia ClinicalTrials.gov
    0 min preload OTHER Approved Postprandial Hyperglycemia ClinicalTrials.gov
    Co-ingestion OTHER Approved Postprandial Hyperglycemia ClinicalTrials.gov
    active control placebo DRUG Phase PHASE1 Peripheral Neuropathic Pain ClinicalTrials.gov
    SR419 placebo DRUG Phase PHASE1 Peripheral Neuropathic Pain ClinicalTrials.gov
    active control DRUG Phase PHASE1 Peripheral Neuropathic Pain ClinicalTrials.gov
    Aspirin Enteric-coated Tablets & Atorvastatin Calcium DRUG Phase PHASE1 Cerebral Infarction ClinicalTrials.gov
    Allogeneic umbilical cord mesenchymal stem cell BIOLOGICAL Phase PHASE1 Cerebral Infarction ClinicalTrials.gov
    TL117 DRUG Phase PHASE1 Head and Neck Squamous Cell Carcinoma ClinicalTrials.gov
    CAR-T (CAR-GPRC5D) DRUG Phase PHASE1 Relapsed/Refractory Multiple Myeloma ClinicalTrials.gov
    anti-CD19-CAR T-cells, or anti-CD30-CAR T-cells, or anti-CD20/CD30-CAR T-cells BIOLOGICAL Phase EARLY_PHASE1 Relapsed/refractory Lymphoma ClinicalTrials.gov
    No Intervention (subjects were previously treated with Equecabtagene Autoleucel Injection) ) OTHER Preclinical Multiple Myeloma ClinicalTrials.gov
    Polycaprolactone microsphere filler DEVICE Approved Nasolabial Fold Correction ClinicalTrials.gov
    Hyaluronate Gel for Injection DEVICE Approved Nasolabial Fold Correction ClinicalTrials.gov
    GT201 injection in combination with teraplizumab injection BIOLOGICAL Approved Adult ClinicalTrials.gov
    ASCT+CD7-CART DRUG Phase PHASE2 CD7 Positive ClinicalTrials.gov
    Live SK08 powder DRUG Phase PHASE2 Ulcerative Colitis (UC) ClinicalTrials.gov
    Cilostazol 200 mg DRUG Phase PHASE3 Intermittent Claudication ClinicalTrials.gov
    Actein effervescent 600mg DRUG Phase PHASE4 COPD (Chronic Obstructive Pulmonary Disease) ClinicalTrials.gov
    microelectrode stimulation of DBS DEVICE Approved Parkinson's Disease and Parkinsonism ClinicalTrials.gov
    HX15001 (MAD) DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    HX15001 (SAD) DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    VIR-2482 (1200 mg) BIOLOGICAL Phase PHASE2 Influenza A ClinicalTrials.gov
    VIR-2482 (450 mg) BIOLOGICAL Phase PHASE2 Influenza A ClinicalTrials.gov
    Positive control BIOLOGICAL Phase PHASE1 Herpes Zoster ClinicalTrials.gov
    High dose adjuvant BIOLOGICAL Phase PHASE1 Herpes Zoster ClinicalTrials.gov
    Low dose adjuvant BIOLOGICAL Phase PHASE1 Herpes Zoster ClinicalTrials.gov
    High Dose Recombinant Herpes Zoster Vaccine (CHO cells) BIOLOGICAL Phase PHASE1 Herpes Zoster ClinicalTrials.gov
    Low Dose Recombinant Herpes Zoster Vaccine (CHO cells) BIOLOGICAL Phase PHASE1 Herpes Zoster ClinicalTrials.gov
    ATRA DRUG Approved Triple-negative Breast Cancer ClinicalTrials.gov
    Saline Solution OTHER Approved Androgenetic Alopecia ClinicalTrials.gov
    PRGF-Endoret DEVICE Approved Androgenetic Alopecia ClinicalTrials.gov
    hUC-MSCs treatment （Double dose） BIOLOGICAL Phase PHASE1 Systemic Lupus Erythematosus (SLE) ClinicalTrials.gov
    hUC-MSCs treatment (medium dose) BIOLOGICAL Phase PHASE1 Systemic Lupus Erythematosus (SLE) ClinicalTrials.gov
    Unfermented meat alternative OTHER Approved Metabolic Syndrome ClinicalTrials.gov
    Fermented meat alternative OTHER Approved Metabolic Syndrome ClinicalTrials.gov
    Osimertinib DRUG Phase PHASE2 Non-Small-Cell Lung Cancer ClinicalTrials.gov
    Treatment of MNC-168 enteric-coated capsules as a single oral drug DRUG Phase PHASE1 Advanced Malignant Solid Tumors ClinicalTrials.gov
    standard isocalorie diet OTHER Approved Non-alcoholic Fatty Liver Disease NAFLD ClinicalTrials.gov
    Specialized food - Plant-Based Meat Analog OTHER Approved Non-alcoholic Fatty Liver Disease NAFLD ClinicalTrials.gov
    Semaglutide Injection (Ozempic®) DRUG Phase PHASE2 Type 2 Diabetes Mellitus (T2DM) ClinicalTrials.gov
    177Lu-LNC1004 Injection group 4 radionuclide therapy DRUG Phase PHASE1 Solid Tumor, Unspecified, Adult ClinicalTrials.gov
    177Lu-LNC1004 Injection group 3 radionuclide therapy DRUG Phase PHASE1 Solid Tumor, Unspecified, Adult ClinicalTrials.gov
    177Lu-LNC1004 Injection group 2 radionuclide therapy DRUG Phase PHASE1 Solid Tumor, Unspecified, Adult ClinicalTrials.gov
    177Lu-LNC1004 Injection group 1 radionuclide therapy DRUG Phase PHASE1 Solid Tumor, Unspecified, Adult ClinicalTrials.gov
    SV001 DRUG Phase EARLY_PHASE1 Idiopathic Pulmonary Fibrosis ClinicalTrials.gov
    Anti-CD19-CAR-T cells GENETIC Phase EARLY_PHASE1 B-Cell Malignancy ClinicalTrials.gov
    Iron Sucrose injection (Reference product, Venofer) and Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) DRUG Phase PHASE1 Bioequivalency ClinicalTrials.gov
    Iron Sucrose injection (Test product, manufactured by Sichuan Huiyu Pharmaceutical Co., Ltd) and Iron Sucrose injection (Reference product, Venofer) DRUG Phase PHASE1 Bioequivalency ClinicalTrials.gov
    HEKT cell BIOLOGICAL Phase PHASE1 Non Small Cell Lung Cancer ClinicalTrials.gov
    FL115+BCG DRUG Phase PHASE1 Non-muscle Invasive Bladder Cancer (NMIBC) ClinicalTrials.gov
    CD33/CD123/CLL-1 CAR-T Cells DRUG Phase PHASE1 Myeloid Malignancies ClinicalTrials.gov
    Paclitaxel injection DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Paclitaxel Micelles for Injection DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    SR1375 capsules DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    ANS014004 DRUG Phase PHASE1 Locally Advanced or Metastatic Solid Tumors ClinicalTrials.gov
    Bivalent RSV Vaccine (IN006) BIOLOGICAL Phase PHASE1 Respiratory Syncytial Virus Infections ClinicalTrials.gov
    Placebo to match GST-HG131 DRUG Phase PHASE2 Chronic Hepatitis B ClinicalTrials.gov
    GST-HG131 DRUG Phase PHASE2 Chronic Hepatitis B ClinicalTrials.gov
    Observation Only OTHER Preclinical Rabies Exposure ClinicalTrials.gov
    GRAN® DRUG Phase PHASE3 Breast Cancer ClinicalTrials.gov
    Behavioral: Post- meal satiety and subsequent ad-libitum meal energy intake OTHER Approved Healthy Male Adults Participants ClinicalTrials.gov
    specialized food based on ice cream, order 3 OTHER Approved Ineffective Esophageal Motility ClinicalTrials.gov
    specialized food based on ice cream, order 2 OTHER Approved Ineffective Esophageal Motility ClinicalTrials.gov
    specialized food based on ice cream, order 1 OTHER Approved Ineffective Esophageal Motility ClinicalTrials.gov
    No dental stent OTHER Phase PHASE2 Nasopharyngeal Carcinoma ClinicalTrials.gov
    Dental stent DEVICE Phase PHASE2 Nasopharyngeal Carcinoma ClinicalTrials.gov
    Herpes Zoster Vaccine, Live BIOLOGICAL Phase PHASE4 Prevention of Herpes Zoster ClinicalTrials.gov
    Moxifloxacin 400 mg DRUG Phase PHASE2 Pneumonia ClinicalTrials.gov
    Nemonoxacin 650 mg DRUG Phase PHASE2 Pneumonia ClinicalTrials.gov
    Nemonoxacin 500 mg DRUG Phase PHASE2 Pneumonia ClinicalTrials.gov
    Decitabine DRUG Phase PHASE1 Myelodysplastic Syndromes ClinicalTrials.gov
    Allogeneic umbilical cord mesenchymal stem cells BIOLOGICAL Phase PHASE1 Myelodysplastic Syndromes ClinicalTrials.gov
    GT316 BIOLOGICAL Phase EARLY_PHASE1 Solid Tumor ClinicalTrials.gov
    Platelet-Rich Plasma (PRP) Intra-articular Injection DEVICE Approved Knee Osteoarthritis ClinicalTrials.gov
    Concentrated Growth Factor (CGF) Intra-articular Injection DEVICE Approved Knee Osteoarthritis ClinicalTrials.gov
    BA1106 DRUG Phase PHASE1 Solid Tumors ClinicalTrials.gov
    Ferric Carboxymaltose Injection [Injectafer®] DRUG Phase PHASE1 Healthy Adult ClinicalTrials.gov
    Ferric Carboxymaltose Injection DRUG Phase PHASE1 Healthy Adult ClinicalTrials.gov
    Tebentafusp DRUG Phase PHASE1 Advanced or Metastatic Solid Tumors ClinicalTrials.gov
    DCSZ11 DRUG Phase PHASE1 Advanced or Metastatic Solid Tumors ClinicalTrials.gov
    GT201 injection BIOLOGICAL Approved Adult ClinicalTrials.gov
    Single leg immobilisation BEHAVIORAL Approved Muscular Atrophy ClinicalTrials.gov
    Respiratory Syncytial Virus IN006 Bivalent mRNA Vaccine (IN006) BIOLOGICAL Phase PHASE2 Respiratory Syncytial Virus (RSV) Infection ClinicalTrials.gov
    Stimus BIOLOGICAL Phase PHASE1 Chronic Kidney Disease ClinicalTrials.gov
    NGGT002 GENETIC Phase PHASE1 Phenylketonurias ClinicalTrials.gov
    Placebo onitment DRUG Phase PHASE1 Atopic Dermatitis ClinicalTrials.gov
    GM-XANTHO onitment DRUG Phase PHASE1 Atopic Dermatitis ClinicalTrials.gov
    Corticosteroid solution (Celestone Cronodose suspension for injection) in saline solution. DRUG Phase PHASE4 Diseases [C] - Musculoskeletal Diseases [C05 ClinicalTrials.gov
    Plasma Rich in Growth Factors (PRGF) DRUG Phase PHASE4 Diseases [C] - Musculoskeletal Diseases [C05 ClinicalTrials.gov
    AMX-500 (SAR446329) DRUG Phase PHASE1 Hormone-refractory Prostate Cancer ClinicalTrials.gov
    Diet modification BEHAVIORAL Phase PHASE3 Pelvic Floor Prolapse ClinicalTrials.gov
    Pelvic floor muscles training BEHAVIORAL Phase PHASE3 Pelvic Floor Prolapse ClinicalTrials.gov
    Tibial neuromodulation PROCEDURE Phase PHASE3 Pelvic Floor Prolapse ClinicalTrials.gov
    Biofeedback therapy PROCEDURE Phase PHASE3 Pelvic Floor Prolapse ClinicalTrials.gov
    Placebo capsule+regular treatments DRUG Phase PHASE2 Community-acquired Pneumonia ClinicalTrials.gov
    SR1375 capsule 0.3mg+regular treatments DRUG Phase PHASE2 Community-acquired Pneumonia ClinicalTrials.gov
    SR1375 capsule 1mg+regular treatments DRUG Phase PHASE2 Community-acquired Pneumonia ClinicalTrials.gov
    SR1375 capsule 3mg+regular treatments DRUG Phase PHASE2 Community-acquired Pneumonia ClinicalTrials.gov
    Purdue Pegboard OTHER Approved Hypothermia ClinicalTrials.gov
    Terpinolene in olive oil OTHER Approved Pharmacokinetics of Terpinolene ClinicalTrials.gov
    Multimodal Lifestyle Intervention BEHAVIORAL Approved Cognitive Impairment ClinicalTrials.gov
    Aspirin Tablet DRUG Phase PHASE1 Cerebral Infarction ClinicalTrials.gov
    GM-XANTHO DRUG Phase PHASE2 Pressure Ulcer ClinicalTrials.gov
    Erythropoietin alfa BIOLOGICAL Phase PHASE1 Natural Blood and Blood Product Toxicity ClinicalTrials.gov
    Measles-Mumps-Rubella Vaccine BIOLOGICAL Phase PHASE4 Japanese Encephalitis ClinicalTrials.gov
    Vero cell-drived inactive Japanese encephalitis vaccine BIOLOGICAL Phase PHASE4 Japanese Encephalitis ClinicalTrials.gov
    Device: Phase II lower than the MTD in Phase I BIOLOGICAL Phase PHASE1 Intracerebral Hemorrhage ClinicalTrials.gov
    Device: Phase II MTD in Phase I BIOLOGICAL Phase PHASE1 Intracerebral Hemorrhage ClinicalTrials.gov
    Device: Phase Ⅰ Dose Level 3 BIOLOGICAL Phase PHASE1 Intracerebral Hemorrhage ClinicalTrials.gov
    Device: Phase Ⅰ Dose Level 2 BIOLOGICAL Phase PHASE1 Intracerebral Hemorrhage ClinicalTrials.gov
    Device: Phase Ⅰ Dose Level 1 BIOLOGICAL Phase PHASE1 Intracerebral Hemorrhage ClinicalTrials.gov
    yogurt intervention OTHER Approved Defecation Irregularity ClinicalTrials.gov
    XELOX DRUG Phase PHASE2 Colon Cancer ClinicalTrials.gov
    FOLFOXIRI DRUG Phase PHASE2 Colon Cancer ClinicalTrials.gov
    SNC109 DRUG Phase PHASE1 Recurrent Glioblastoma Multiforme (GBM) ClinicalTrials.gov
    Ribavirin Oral Product DRUG Phase PHASE4 Chronic Hepatitis C ClinicalTrials.gov
    Peginterferon Alfa-2A DRUG Phase PHASE4 Chronic Hepatitis C ClinicalTrials.gov
    anti-CD70-CAR-T cells BIOLOGICAL Phase EARLY_PHASE1 Renal Cell Carcinoma ClinicalTrials.gov
    Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)(high dose) BIOLOGICAL Phase PHASE1 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)(low dose) BIOLOGICAL Phase PHASE1 Respiratory Syncytial Virus (RSV) ClinicalTrials.gov
    SPOT-mRNA01 BIOLOGICAL Phase PHASE1 Skin Aging ClinicalTrials.gov
    KRAS-specific Autologous TCR-T cell injection DRUG Phase PHASE1 Colorectal ClinicalTrials.gov
    Trained Healthcare Provider BEHAVIORAL Approved Whole Genome Sequencing ClinicalTrials.gov
    Genetic Counselor BEHAVIORAL Approved Whole Genome Sequencing ClinicalTrials.gov
    No use of antisecretory agents BEHAVIORAL Approved Gastroesophageal Reflux Disease ClinicalTrials.gov
    Use of antisecretory agents BEHAVIORAL Approved Gastroesophageal Reflux Disease ClinicalTrials.gov
    No change in physical activity BEHAVIORAL Approved Gastroesophageal Reflux Disease ClinicalTrials.gov
    Change in physical activity BEHAVIORAL Approved Gastroesophageal Reflux Disease ClinicalTrials.gov
    No diet adherence BEHAVIORAL Approved Gastroesophageal Reflux Disease ClinicalTrials.gov
    diet adherence BEHAVIORAL Approved Gastroesophageal Reflux Disease ClinicalTrials.gov
    anti-CD20/CD30-CAR-T cells GENETIC Phase EARLY_PHASE1 Relapsed/Refractory Lymphoma ClinicalTrials.gov
    A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Recurrent or Progressive Gliomas of the Brain BIOLOGICAL Phase PHASE1 High-grade Gliomas ClinicalTrials.gov
    Fludarabine + Cyclophosphamide + CD7-specific CAR-T Cells DRUG Phase PHASE1 Hematologic Malignancy ClinicalTrials.gov
    tumor-specific TCR-T cells DRUG Phase PHASE1 Solid Tumor ClinicalTrials.gov
    9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52 and 58) Recombinant Vaccine (Hansenula Polymorpha) BIOLOGICAL Phase PHASE3 Genital Wart ClinicalTrials.gov
    DXC006 DRUG Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Bone marrow mesenchymal stem cells (high dose) DRUG Phase PHASE1 Acute-On-Chronic Liver Failure ClinicalTrials.gov
    Bone marrow mesenchymal stem cells (medium dose) DRUG Phase PHASE1 Acute-On-Chronic Liver Failure ClinicalTrials.gov
    Solvent of CG-BM1 DRUG Phase PHASE1 Acute-On-Chronic Liver Failure ClinicalTrials.gov
    Bone marrow mesenchymal stem cells (low dose) DRUG Phase PHASE1 Acute-On-Chronic Liver Failure ClinicalTrials.gov
    TG-873870 (Nemonoxacin) DRUG Phase PHASE2 Diabetic Foot Infections ClinicalTrials.gov
    Humanized collagen filling crow's feet PROCEDURE Phase PHASE3 Intentional Correction of Forehead Wrinkles (crow's Feet) ClinicalTrials.gov
    Crow's feet injection filling PROCEDURE Phase PHASE3 Intentional Correction of Forehead Wrinkles (crow's Feet) ClinicalTrials.gov
    YTS104 Cells injection BIOLOGICAL Phase PHASE1 Relapsed or Refractory Multiple Myeloma ClinicalTrials.gov
    SR419 capsules DRUG Phase PHASE1 Healthy ClinicalTrials.gov
    Dimethicone emulsion 4ml DRUG Phase PHASE2 Gastric Mucosal Lesion ClinicalTrials.gov
    Recombinant Human Chymotrypsin(OsrhCT) 4000U DRUG Phase PHASE2 Gastric Mucosal Lesion ClinicalTrials.gov
    Cyclophosphamide and fludarabine DRUG Phase EARLY_PHASE1 Autoimmune Diseases ClinicalTrials.gov
    CT103A cells BIOLOGICAL Phase EARLY_PHASE1 Autoimmune Diseases ClinicalTrials.gov
    BRII-179 BIOLOGICAL Phase PHASE2 For Treatment of Chronic Hepatitis B Virus Infection ClinicalTrials.gov
    CD7 CART BIOLOGICAL Approved CD7+ Lymphoma ClinicalTrials.gov
    YTS109 cell injection DRUG Phase PHASE1 Lupus Nephritis (LN) ClinicalTrials.gov
    Nasal swab/Nasopharyngeal swab/Blood draw OTHER Preclinical COVID-19 ClinicalTrials.gov
    Nasal swab/Nasopharyngeal swab/Blood sample collection OTHER Preclinical COVID-19 ClinicalTrials.gov
    Plant based diet OTHER Approved Healthy ClinicalTrials.gov
    Animal protein diet OTHER Approved Healthy ClinicalTrials.gov
    Normal protein diet OTHER Approved Healthy ClinicalTrials.gov
    VIR-1388 BIOLOGICAL Phase PHASE1 HIV I Infection ClinicalTrials.gov
    Capox chemotherapy DRUG Phase PHASE3 Rectal Cancer ClinicalTrials.gov
    PMR 135 mg DRUG Phase PHASE1 Intermittent Claudication ClinicalTrials.gov
    Eque-cel CAR-T Therapy BIOLOGICAL Phase PHASE2 AL Amyloidosis ClinicalTrials.gov
    C402-CD19-CAR BIOLOGICAL Phase PHASE1 Diffuse Large B-cell-lymphoma ClinicalTrials.gov
    HAIC PROCEDURE Preclinical Hepatocellular Carcinoma Non-resectable ClinicalTrials.gov
    Artificial tears eye-drops DRUG Phase PHASE4 Neurotrophic Keratitis ClinicalTrials.gov
    ctDNA-based MRD detection DEVICE Preclinical Pancreatic Cancer Resectable ClinicalTrials.gov
    GTE001 injection BIOLOGICAL Phase PHASE1 Advanced Lung Adenocarcinoma；Adult ClinicalTrials.gov
    SR1375 DRUG Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    collagen implant agent DEVICE Approved Nasolabial Fold Wrinkles ClinicalTrials.gov
    Recombinant collagen gel DEVICE Approved Nasolabial Fold Wrinkles ClinicalTrials.gov
    Gemcitabine injection DRUG Phase PHASE2 Adult ClinicalTrials.gov
    GT101 injection BIOLOGICAL Phase PHASE2 Adult ClinicalTrials.gov
    CAR-T-19 cell injection BIOLOGICAL Phase PHASE2 Relapsed B-cell Acute Lymphoblastic Leukemia ClinicalTrials.gov
    DTacP-IPV/Hib BIOLOGICAL Phase PHASE3 Prevent Whooping Cough ClinicalTrials.gov
    DTaP BIOLOGICAL Phase PHASE3 Prevent Whooping Cough ClinicalTrials.gov
    DTacP BIOLOGICAL Phase PHASE3 Prevent Whooping Cough ClinicalTrials.gov
    AMX-818 DRUG Phase PHASE1 Locally Advanced or Metastatic HER2-Expressing Cancers ClinicalTrials.gov
    Allogeneic hematopoietic stem cell transplantation OTHER Phase PHASE1 Hematologic Diseases ClinicalTrials.gov
    CD7 CAR-T cells injection DRUG Phase PHASE1 Hematologic Diseases ClinicalTrials.gov
    CAR-T cells injection DRUG Phase PHASE1 Neuromyelitis Optica ClinicalTrials.gov
    CD117 CAR T-cells BIOLOGICAL Phase EARLY_PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Vir Biotechnology
    • Ticker Symbol: VIR

Search

News categories